{
  "meta": {
    "id": "test58",
    "title": "Mid Day Module (OBG-5) - 2025-03-07",
    "category": "Subject Wise / Mixed"
  },
  "questions": [
    {
      "text": "A 16-year-old girl presents to OPD and the below examination finding is seen. Which of the following is least likely?",
      "options": [
        {
          "label": "A",
          "text": "Associated with hematometra and hamatocolpos",
          "correct": false
        },
        {
          "label": "B",
          "text": "Cyclic pelvic pain is experienced",
          "correct": false
        },
        {
          "label": "C",
          "text": "Breast development is absent/ delayed",
          "correct": true
        },
        {
          "label": "D",
          "text": "Cruciate incision will relieve symptoms",
          "correct": false
        }
      ],
      "correct_answer": "C. Breast development is absent/ delayed",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/whatsapp-image-2023-04-29-at-154259.jpeg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Breast development is absent/ delayed</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Ref: Speroff\u2019s 9 th edition chapter 10, amenorrhea</li><li>\u27a4 Ref: Speroff\u2019s 9 th edition chapter 10, amenorrhea</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7f76ffa0",
      "audio": ""
    },
    {
      "text": "A 17-year-old girl presents to OPD with cyclic pelvic pain local examination reveals the below image. The diagnosis is?",
      "options": [
        {
          "label": "A",
          "text": "Transverse vaginal septum",
          "correct": false
        },
        {
          "label": "B",
          "text": "Imperforate hymen",
          "correct": true
        },
        {
          "label": "C",
          "text": "MRKH",
          "correct": false
        },
        {
          "label": "D",
          "text": "Nulliparous prolapse",
          "correct": false
        }
      ],
      "correct_answer": "B. Imperforate hymen",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/27/picture2_D8Jfh1v.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Imperforate hymen</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Ref: Speroff\u2019s 9 th edition chapter 10, amenorhea</li><li>\u27a4 Ref: Speroff\u2019s 9 th edition chapter 10, amenorhea</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0c3f5ee7",
      "audio": ""
    },
    {
      "text": "A 16-year-old girl presents to OPD with primary amenorrhea and cyclic pelvic pain. On rectal examination, a bulge is felt anteriorly, 4 cm from anal verge. The likely diagnosis is:",
      "options": [
        {
          "label": "A",
          "text": "Transverse vaginal septum",
          "correct": true
        },
        {
          "label": "B",
          "text": "Imperforate hymen",
          "correct": false
        },
        {
          "label": "C",
          "text": "Mullerian agenesis",
          "correct": false
        },
        {
          "label": "D",
          "text": "OHVIRA syndrome",
          "correct": false
        }
      ],
      "correct_answer": "A. Transverse vaginal septum",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/13/screenshot-2024-03-13-105747.jpg"
      ],
      "explanation": "<p><strong>Ans. A. Transverse vaginal septum</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Ref: Speroff\u2019s 9 th edition chapter 10, amenorrhea</li><li>\u27a4 Ref: Speroff\u2019s 9 th edition chapter 10, amenorrhea</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "019e1e97",
      "audio": ""
    },
    {
      "text": "A 17-year-old woman presents to OPD with painful menstruation. On examination, normal secondary sexual characters are present. The vagina is patent but shows a bulge on the right side near the cervix. On per rectal examination, there is a bulge felt about 4 cm from anal verge and is more towards left side. On Ultrasound, there is hematocolpos and the left side kidney is absent. Diagnosis is:",
      "options": [
        {
          "label": "A",
          "text": "OHVIRA syndrome",
          "correct": true
        },
        {
          "label": "B",
          "text": "MRKH syndrome",
          "correct": false
        },
        {
          "label": "C",
          "text": "ACUM",
          "correct": false
        },
        {
          "label": "D",
          "text": "Robert\u2019s uterus",
          "correct": false
        }
      ],
      "correct_answer": "A. OHVIRA syndrome",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/13/screenshot-2024-03-13-105747_O1cNPjD.jpg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/13/screenshot-2024-03-13-110058.jpg"
      ],
      "explanation": "<p><strong>Ans. A. OHVIRA syndrome</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Ref: Speroff\u2019s 9 th edition chapter 10, amenorrhea</li><li>\u27a4 Ref: Speroff\u2019s 9 th edition chapter 10, amenorrhea</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "54b07c05",
      "audio": ""
    },
    {
      "text": "A 18 year old girl presents to OPD with primary amenorrhea, normal breast and pubic & axillary hair development. On examination, vagina is absent and there is inguinal hernia. Serum estradiol and FSH level are normal. USG shows absent uterus and vagina. The likely diagnosis is:",
      "options": [
        {
          "label": "A",
          "text": "Complete AIS",
          "correct": false
        },
        {
          "label": "B",
          "text": "Partial AIS",
          "correct": false
        },
        {
          "label": "C",
          "text": "MRKH",
          "correct": true
        },
        {
          "label": "D",
          "text": "Swyer syndrome",
          "correct": false
        }
      ],
      "correct_answer": "C. MRKH",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. MRKH</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Ref: Speroff\u2019s 9 th edition chapter 10, amenorrhea</li><li>\u27a4 Ref: Speroff\u2019s 9 th edition chapter 10, amenorrhea</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "49f7d977",
      "audio": ""
    },
    {
      "text": "A 20-year-old girl presents to OPD with primary amenorrhea and evaluation reveals MRKH. Treatment for patients with MRKH includes:",
      "options": [
        {
          "label": "A",
          "text": "Vaginoplasty",
          "correct": false
        },
        {
          "label": "B",
          "text": "Vaginoplasty, and IVF with self-oocyte and surrogacy",
          "correct": true
        },
        {
          "label": "C",
          "text": "Vaginoplasty and IVF with donor oocyte and surrogacy",
          "correct": false
        },
        {
          "label": "D",
          "text": "Vaginoplasty and donor embryo and surrogacy",
          "correct": false
        }
      ],
      "correct_answer": "B. Vaginoplasty, and IVF with self-oocyte and surrogacy",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Vaginoplasty, and IVF with self-oocyte and surrogacy</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Ref: Speroff\u2019s 9 th edition chapter 10, amenorrhea</li><li>\u27a4 Ref: Speroff\u2019s 9 th edition chapter 10, amenorrhea</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3c20242f",
      "audio": ""
    },
    {
      "text": "A 20-year-old girl presents to OPD with primary amenorrhea. Height is 160 cm, has normal breast development and scant pubic hair. The uterus and vagina are absent. Which of the following is true?",
      "options": [
        {
          "label": "A",
          "text": "Karyotype will most likely be 46XX",
          "correct": false
        },
        {
          "label": "B",
          "text": "Associated with renal and skeletal anomalies",
          "correct": false
        },
        {
          "label": "C",
          "text": "Gonadectomy and vaginoplasty are recommended treatment",
          "correct": true
        },
        {
          "label": "D",
          "text": "Immediate Gonadectomy is done immediately in complete AIS",
          "correct": false
        }
      ],
      "correct_answer": "C. Gonadectomy and vaginoplasty are recommended treatment",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Gonadectomy and vaginoplasty are recommended treatment</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Ref: Speroff\u2019s 9 th edition chapter 10, amenorrhea</li><li>\u27a4 Ref: Speroff\u2019s 9 th edition chapter 10, amenorrhea</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4e9a0778",
      "audio": ""
    },
    {
      "text": "A 21-year-old girl presents to OPD with primary amenorrhea, she has normal breast development and scant pubic hair. Labia minora are small and vagina is absent. Which of the following is most likely to be associated with this:",
      "options": [
        {
          "label": "A",
          "text": "Renal anomalies",
          "correct": false
        },
        {
          "label": "B",
          "text": "Skeletal anomalies",
          "correct": false
        },
        {
          "label": "C",
          "text": "Inguinal hernia",
          "correct": true
        },
        {
          "label": "D",
          "text": "Clitoromegaly",
          "correct": false
        }
      ],
      "correct_answer": "C. Inguinal hernia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Inguinal hernia</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Ref: Speroff\u2019s 9 th edition chapter 10, amenorrhea</li><li>\u27a4 Ref: Speroff\u2019s 9 th edition chapter 10, amenorrhea</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8ef662ec",
      "audio": ""
    },
    {
      "text": "A 14-year-old girl presents to OPD with primary amenorrhea. Her height is 135 cm. She has a webbed neck and increased carrying angle. Breast development is tanner 1 with widely spaced nipple, external genitalia are infantile. The Karyotype is most likely to reveal:",
      "options": [
        {
          "label": "A",
          "text": "46 XX",
          "correct": false
        },
        {
          "label": "B",
          "text": "46XY",
          "correct": false
        },
        {
          "label": "C",
          "text": "45 X0",
          "correct": true
        },
        {
          "label": "D",
          "text": "47 XXY",
          "correct": false
        }
      ],
      "correct_answer": "C. 45 X0",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. 45 X0</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Ref: Speroff\u2019s 9 th edition chapter 10, amenorrhea</li><li>\u27a4 Ref: Speroff\u2019s 9 th edition chapter 10, amenorrhea</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "887e2a6c",
      "audio": ""
    },
    {
      "text": "A 13-year-old girl with primary amenorrhea, short stature, and hypergonadotropic hypogonadism. Karyotype reveals 45X0. What is the next line of management?",
      "options": [
        {
          "label": "A",
          "text": "Estrogen therapy",
          "correct": false
        },
        {
          "label": "B",
          "text": "Cyclic Estrogen and progesterone therapy",
          "correct": false
        },
        {
          "label": "C",
          "text": "Growth hormone and Estrogen therapy",
          "correct": true
        },
        {
          "label": "D",
          "text": "Growth hormone and cyclic Estrogen-progesterone therapy",
          "correct": false
        }
      ],
      "correct_answer": "C. Growth hormone and Estrogen therapy",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Growth hormone and Estrogen therapy</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Ref: Speroff\u2019s 9 th edition chapter 10, amenorrhea</li><li>\u27a4 Ref: Speroff\u2019s 9 th edition chapter 10, amenorrhea</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "089d5e3b",
      "audio": ""
    },
    {
      "text": "A 17-year-old girl presents to OPD for not having attained menses till now. On examination, height is 170 cm, breasts are not well developed, pubic hair are absent, external genitalia are normal and vagina and uterus are present. Serum FSH is high. What is the next step?",
      "options": [
        {
          "label": "A",
          "text": "Karyotype",
          "correct": true
        },
        {
          "label": "B",
          "text": "Cyclic Estrogen and progesterone",
          "correct": false
        },
        {
          "label": "C",
          "text": "Gonadectomy",
          "correct": false
        },
        {
          "label": "D",
          "text": "Vaginoplasty",
          "correct": false
        }
      ],
      "correct_answer": "A. Karyotype",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Karyotype</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Ref: Speroff\u2019s 9 th edition chapter 10, amenorrhea</li><li>\u27a4 Ref: Speroff\u2019s 9 th edition chapter 10, amenorrhea</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6f835399",
      "audio": ""
    },
    {
      "text": "A 16y girl is brought to the OPD as she has not started her period. The patients 14y sister underwent menarche 2 years earlier and her mother began menstruating at age 13. She has no weight gain, headaches, nipple discharge or abdominal pain. She is not sexually active and is not using any method of contraception. She is physically active and is on her school\u2019s basketball team. Her breast exam and pubic hair are Tanner stage IV. The abdomen is soft. The external genitalia appear normal. The vagina ends in a blind pouch. An ultrasound reveals ovaries, but no cervix or uterus is seen. Which is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Androgen insensitivity syndrome",
          "correct": false
        },
        {
          "label": "B",
          "text": "Constitutional delay",
          "correct": false
        },
        {
          "label": "C",
          "text": "Functional hypothalamic amenorrhoea",
          "correct": false
        },
        {
          "label": "D",
          "text": "Mullerian agenesis",
          "correct": true
        }
      ],
      "correct_answer": "D. Mullerian agenesis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Mullerian agenesis</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Ref: Speroff\u2019s 9 th edition chapter 10, amenorrhea</li><li>\u27a4 Ref:</li><li>\u27a4 Speroff\u2019s 9 th edition chapter 10, amenorrhea</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "aa004922",
      "audio": ""
    },
    {
      "text": "A 30-year female presents to OPD with secondary amenorrhea. She does not bleed on the progesterone challenge or even after giving her a course of combined estrogen and progesterone pills. Asherman syndrome is suspected. This can result from. Curettage Tuberculosis Uterine artery embolization Cesareans section Cervical biopsy",
      "options": [
        {
          "label": "A",
          "text": "A, B, C, D, E",
          "correct": false
        },
        {
          "label": "B",
          "text": "A, B, C, D",
          "correct": true
        },
        {
          "label": "C",
          "text": "A, B",
          "correct": false
        },
        {
          "label": "D",
          "text": "A,B,D",
          "correct": false
        }
      ],
      "correct_answer": "B. A, B, C, D",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. A, B, C, D</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Asherman syndrome is typically caused by intrauterine trauma or surgery (like curettage or uterine artery embolization), certain infections (like genital tuberculosis), and less commonly by cesarean sections. Understanding these causes is essential for preventing and managing Asherman syndrome, which can lead to secondary amenorrhea and infertility</li><li>\u27a4 Asherman syndrome is intrauterine adhesions or synechiae They arise due to Surgical trauma to the uterus which may be seen following Dilatation and curettage (esp sharp curettage) Cesarean section Myomectomy where the endometrial cavity is involved Metroplasty Trans-cervical resection of the endometrium Uterine artery embolization Endometrial ablative procedures Intra-uterine infections like tuberculosis and schistosomiasis</li><li>\u27a4 Asherman syndrome is intrauterine adhesions or synechiae</li><li>\u27a4 They arise due to Surgical trauma to the uterus which may be seen following Dilatation and curettage (esp sharp curettage) Cesarean section Myomectomy where the endometrial cavity is involved Metroplasty Trans-cervical resection of the endometrium Uterine artery embolization Endometrial ablative procedures Intra-uterine infections like tuberculosis and schistosomiasis</li><li>\u27a4 Surgical trauma to the uterus which may be seen following Dilatation and curettage (esp sharp curettage) Cesarean section Myomectomy where the endometrial cavity is involved Metroplasty Trans-cervical resection of the endometrium Uterine artery embolization Endometrial ablative procedures Intra-uterine infections like tuberculosis and schistosomiasis</li><li>\u27a4 Surgical trauma to the uterus which may be seen following Dilatation and curettage (esp sharp curettage) Cesarean section Myomectomy where the endometrial cavity is involved Metroplasty Trans-cervical resection of the endometrium</li><li>\u27a4 Dilatation and curettage (esp sharp curettage) Cesarean section Myomectomy where the endometrial cavity is involved Metroplasty Trans-cervical resection of the endometrium</li><li>\u27a4 Dilatation and curettage (esp sharp curettage)</li><li>\u27a4 Cesarean section</li><li>\u27a4 Myomectomy where the endometrial cavity is involved</li><li>\u27a4 Metroplasty</li><li>\u27a4 Trans-cervical resection of the endometrium</li><li>\u27a4 Uterine artery embolization</li><li>\u27a4 Endometrial ablative procedures</li><li>\u27a4 Intra-uterine infections like tuberculosis and schistosomiasis</li><li>\u27a4 But the classical history is usually after a D & C, the patient develops amenorrhoea</li><li>\u27a4 But the classical history is usually after a D & C, the patient develops amenorrhoea</li><li>\u27a4 Symptoms: Hypomenorrhea Secondary amenorrhoea Secondary infertility Diagnosis On ultrasound: Uterine cavity appears irregular/ interrupted; punctate echogenic foci in the endometrium/ indistinct endo-myometrial junction/ endometrial fluid: commonly loculated appearing as small focal cystic areas within the endometrium On HSG Intra-uterine filling defects are seen giving a moth-eaten appearance Hysteroscopy Gold standard for diagnosis</li><li>\u27a4 Symptoms: Hypomenorrhea Secondary amenorrhoea Secondary infertility</li><li>\u27a4 Hypomenorrhea Secondary amenorrhoea Secondary infertility</li><li>\u27a4 Hypomenorrhea</li><li>\u27a4 Secondary amenorrhoea</li><li>\u27a4 Secondary infertility</li><li>\u27a4 Diagnosis On ultrasound: Uterine cavity appears irregular/ interrupted; punctate echogenic foci in the endometrium/ indistinct endo-myometrial junction/ endometrial fluid: commonly loculated appearing as small focal cystic areas within the endometrium On HSG Intra-uterine filling defects are seen giving a moth-eaten appearance Hysteroscopy Gold standard for diagnosis</li><li>\u27a4 On ultrasound: Uterine cavity appears irregular/ interrupted; punctate echogenic foci in the endometrium/ indistinct endo-myometrial junction/ endometrial fluid: commonly loculated appearing as small focal cystic areas within the endometrium On HSG Intra-uterine filling defects are seen giving a moth-eaten appearance Hysteroscopy Gold standard for diagnosis</li><li>\u27a4 On ultrasound:</li><li>\u27a4 Uterine cavity appears irregular/ interrupted; punctate echogenic foci in the endometrium/ indistinct endo-myometrial junction/ endometrial fluid: commonly loculated appearing as small focal cystic areas within the endometrium</li><li>\u27a4 On HSG</li><li>\u27a4 Intra-uterine filling defects are seen giving a moth-eaten appearance</li><li>\u27a4 Hysteroscopy Gold standard for diagnosis</li><li>\u27a4 Gold standard for diagnosis</li><li>\u27a4 Gold standard for diagnosis</li><li>\u27a4 Treatment: Hysteroscopic adhesiolysis Post procedure: To stimulate endometrial proliferation and prevent reformation of adhesions, oral oestrogen administration has proved effective. A cooper containing intra-uterine device can also be inserted to prevent reformation of adhesions Another hysteroscopy or HSG is typically performed at 3 months following the initial resection.</li><li>\u27a4 Treatment: Hysteroscopic adhesiolysis Post procedure: To stimulate endometrial proliferation and prevent reformation of adhesions, oral oestrogen administration has proved effective. A cooper containing intra-uterine device can also be inserted to prevent reformation of adhesions Another hysteroscopy or HSG is typically performed at 3 months following the initial resection.</li><li>\u27a4 Hysteroscopic adhesiolysis Post procedure: To stimulate endometrial proliferation and prevent reformation of adhesions, oral oestrogen administration has proved effective. A cooper containing intra-uterine device can also be inserted to prevent reformation of adhesions Another hysteroscopy or HSG is typically performed at 3 months following the initial resection.</li><li>\u27a4 Hysteroscopic adhesiolysis</li><li>\u27a4 Post procedure: To stimulate endometrial proliferation and prevent reformation of adhesions, oral oestrogen administration has proved effective. A cooper containing intra-uterine device can also be inserted to prevent reformation of adhesions Another hysteroscopy or HSG is typically performed at 3 months following the initial resection.</li><li>\u27a4 To stimulate endometrial proliferation and prevent reformation of adhesions, oral oestrogen administration has proved effective. A cooper containing intra-uterine device can also be inserted to prevent reformation of adhesions Another hysteroscopy or HSG is typically performed at 3 months following the initial resection.</li><li>\u27a4 To stimulate endometrial proliferation and prevent reformation of adhesions, oral oestrogen administration has proved effective. A cooper containing intra-uterine device can also be inserted to prevent reformation of adhesions</li><li>\u27a4 Another hysteroscopy or HSG is typically performed at 3 months following the initial resection.</li><li>\u27a4 Ref: Page 1080, William\u2019s gynecology, 3 rd edition</li><li>\u27a4 Ref: Page 1080, William\u2019s gynecology, 3 rd edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "73f83bd3",
      "audio": ""
    },
    {
      "text": "A 30-year-old female presents to OPD with secondary amenorrhea for 2 years. Her BMI is 30 kg/m2. She has no withdrawal bleeding after progesterone or after estrogen and progesterone. The likely cause is:",
      "options": [
        {
          "label": "A",
          "text": "PCOS",
          "correct": false
        },
        {
          "label": "B",
          "text": "Asherman syndrome",
          "correct": true
        },
        {
          "label": "C",
          "text": "Cervical stenosis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Gonadal dysgenesis",
          "correct": false
        }
      ],
      "correct_answer": "B. Asherman syndrome",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Asherman syndrome</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 About Asherman Syndrome:</li><li>\u27a4 About Asherman Syndrome:</li><li>\u27a4 The diagnosis of Asherman syndrome is based primarily on a high index of suspicion, based on history. In women whose history suggests this possibility, scant or no withdrawal bleeding after sequential treatment with exogenous estrogen and progestin reflects end-organ endometrial failure and corroborates the clinical suspicion. Asherman syndrome is intra uterine adhesions. They arise due to: Surgical trauma to the uterus which may be seen following Dilatation and curettage (esp sharp curettage) Cesarean section Myomectomy where the endometrial cavity is involved Metroplasty Trans-cervical resection of the endometrium Uterine artery embolization Endometrial ablative procedures Intra-uterine infections like tuberculosis and schistosomiasis Symptoms: Hypomenorrhea Secondary amenorrhoea Secondary infertility Diagnosis On ultrasound Uterine cavity appears irregular/ i nterrupted; punctate echogenic foci in the endometrium/ indistinct endo-myometrial junction/ endometrial fluid: commonly loculated appearing as small focal cystic areas within the endometrium</li><li>\u27a4 The diagnosis of Asherman syndrome is based primarily on a high index of suspicion, based on history. In women whose history suggests this possibility, scant or no withdrawal bleeding after sequential treatment with exogenous estrogen and progestin reflects end-organ endometrial failure and corroborates the clinical suspicion.</li><li>\u27a4 Asherman syndrome is intra uterine adhesions.</li><li>\u27a4 They arise due to: Surgical trauma to the uterus which may be seen following Dilatation and curettage (esp sharp curettage) Cesarean section Myomectomy where the endometrial cavity is involved Metroplasty Trans-cervical resection of the endometrium Uterine artery embolization Endometrial ablative procedures Intra-uterine infections like tuberculosis and schistosomiasis</li><li>\u27a4 Surgical trauma to the uterus which may be seen following Dilatation and curettage (esp sharp curettage) Cesarean section Myomectomy where the endometrial cavity is involved Metroplasty Trans-cervical resection of the endometrium Uterine artery embolization Endometrial ablative procedures Intra-uterine infections like tuberculosis and schistosomiasis</li><li>\u27a4 Surgical trauma to the uterus which may be seen following Dilatation and curettage (esp sharp curettage) Cesarean section Myomectomy where the endometrial cavity is involved Metroplasty Trans-cervical resection of the endometrium</li><li>\u27a4 Dilatation and curettage (esp sharp curettage) Cesarean section Myomectomy where the endometrial cavity is involved Metroplasty Trans-cervical resection of the endometrium</li><li>\u27a4 Dilatation and curettage (esp sharp curettage)</li><li>\u27a4 Cesarean section</li><li>\u27a4 Myomectomy where the endometrial cavity is involved</li><li>\u27a4 Metroplasty</li><li>\u27a4 Trans-cervical resection of the endometrium</li><li>\u27a4 Uterine artery embolization</li><li>\u27a4 Endometrial ablative procedures</li><li>\u27a4 Intra-uterine infections like tuberculosis and schistosomiasis</li><li>\u27a4 Symptoms: Hypomenorrhea Secondary amenorrhoea Secondary infertility</li><li>\u27a4 Hypomenorrhea Secondary amenorrhoea Secondary infertility</li><li>\u27a4 Hypomenorrhea</li><li>\u27a4 Secondary amenorrhoea</li><li>\u27a4 Secondary infertility</li><li>\u27a4 Diagnosis On ultrasound</li><li>\u27a4 On ultrasound</li><li>\u27a4 On ultrasound</li><li>\u27a4 Uterine cavity appears irregular/ i nterrupted; punctate echogenic foci in the endometrium/ indistinct endo-myometrial junction/ endometrial fluid: commonly loculated appearing as small focal cystic areas within the endometrium</li><li>\u27a4 On HSG Intra-uterine filling defects are seen giving a moth-eaten appearance Hysteroscopy Gold standard for diagnosis</li><li>\u27a4 On HSG Intra-uterine filling defects are seen giving a moth-eaten appearance</li><li>\u27a4 Intra-uterine filling defects are seen giving a moth-eaten appearance</li><li>\u27a4 Intra-uterine filling defects are seen giving a moth-eaten appearance</li><li>\u27a4 Hysteroscopy Gold standard for diagnosis</li><li>\u27a4 Gold standard for diagnosis</li><li>\u27a4 Gold standard for diagnosis</li><li>\u27a4 Treatment: Hysteroscopic adhesiolysis Post procedure: To stimulate endometrial proliferation and prevent reformation of adhesions, oral oestrogen administration has proved effective. A cooper containing intra-uterine device can also be inserted to prevent reformation of adhesions Another hysteroscopy or HSG is typically performed at 3 months following the initial resection.</li><li>\u27a4 Treatment: Hysteroscopic adhesiolysis Post procedure: To stimulate endometrial proliferation and prevent reformation of adhesions, oral oestrogen administration has proved effective. A cooper containing intra-uterine device can also be inserted to prevent reformation of adhesions Another hysteroscopy or HSG is typically performed at 3 months following the initial resection.</li><li>\u27a4 Hysteroscopic adhesiolysis Post procedure: To stimulate endometrial proliferation and prevent reformation of adhesions, oral oestrogen administration has proved effective. A cooper containing intra-uterine device can also be inserted to prevent reformation of adhesions Another hysteroscopy or HSG is typically performed at 3 months following the initial resection.</li><li>\u27a4 Hysteroscopic adhesiolysis</li><li>\u27a4 Post procedure: To stimulate endometrial proliferation and prevent reformation of adhesions, oral oestrogen administration has proved effective. A cooper containing intra-uterine device can also be inserted to prevent reformation of adhesions Another hysteroscopy or HSG is typically performed at 3 months following the initial resection.</li><li>\u27a4 To stimulate endometrial proliferation and prevent reformation of adhesions, oral oestrogen administration has proved effective. A cooper containing intra-uterine device can also be inserted to prevent reformation of adhesions Another hysteroscopy or HSG is typically performed at 3 months following the initial resection.</li><li>\u27a4 To stimulate endometrial proliferation and prevent reformation of adhesions, oral oestrogen administration has proved effective. A cooper containing intra-uterine device can also be inserted to prevent reformation of adhesions</li><li>\u27a4 Another hysteroscopy or HSG is typically performed at 3 months following the initial resection.</li><li>\u27a4 Ref: Speroff\u2019s 9 th edition chapter 10, amenorrhea</li><li>\u27a4 Ref: Speroff\u2019s 9 th edition chapter 10, amenorrhea</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9c0a5f30",
      "audio": ""
    },
    {
      "text": "A 36-year-old P2L2 woman who has undergone a tubal ligation comes to the OPD with amenorrhea 2 years after her ligation. Her FSH is high. Which of the following is the likely diagnosis:",
      "options": [
        {
          "label": "A",
          "text": "Sheehan syndrome",
          "correct": false
        },
        {
          "label": "B",
          "text": "Asherman syndrome",
          "correct": false
        },
        {
          "label": "C",
          "text": "Premature ovarian insufficiency",
          "correct": true
        },
        {
          "label": "D",
          "text": "Polycystic Ovarian syndrome",
          "correct": false
        }
      ],
      "correct_answer": "C. Premature ovarian insufficiency",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Premature ovarian insufficiency</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Ref: Speroff\u2019s 9 th edition chapter 10, amenorrhea</li><li>\u27a4 Ref: Speroff\u2019s 9 th edition chapter 10, amenorrhea</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7156fcba",
      "audio": ""
    },
    {
      "text": "A 30-year-old woman presents to OPD with complaint of secondary amenorrhea. On examination, there is galactorrhoea, and her prolactin levels are high. Urine pregnancy test is negative. Which of the following is treatment of choice for her:",
      "options": [
        {
          "label": "A",
          "text": "OCP",
          "correct": false
        },
        {
          "label": "B",
          "text": "Cabergoline",
          "correct": true
        },
        {
          "label": "C",
          "text": "Dexamethasone",
          "correct": false
        },
        {
          "label": "D",
          "text": "Oxytocin",
          "correct": false
        }
      ],
      "correct_answer": "B. Cabergoline",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Cabergoline</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Ref: Speroff\u2019s 9 th edition chapter 10, amenorrhea</li><li>\u27a4 Ref:</li><li>\u27a4 Speroff\u2019s 9 th edition chapter 10, amenorrhea</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6d6242d6",
      "audio": ""
    },
    {
      "text": "A 30 y comes to OPD for evaluation of absent periods. The patient had a vaginal delivery 8 months ago and she\u2019s not had her period since delivery. Her postpartum course was complicated by secondary PPH requiring blood transfusion and a D & E for retained products. At a visit, 2 months ago, the patient was started on combined OCPs, and she has not had vaginal bleeding. Prior to this pregnancy she had regular monthly cycles. She also has increased fatigue. She is not lactating and is bottle feeding her baby. There is no headache, galactorrhoea, or hot flushes. BMI is 31, vitals are normal. Pelvic examination shows clear vaginal discharge and well rugate vagina. The uterus is small and anteverted. UPT is negative. FSH and TSH are normal. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Asherman syndrome",
          "correct": true
        },
        {
          "label": "B",
          "text": "Sheehan syndrome",
          "correct": false
        },
        {
          "label": "C",
          "text": "PCOS",
          "correct": false
        },
        {
          "label": "D",
          "text": "Primary ovarian insufficiency",
          "correct": false
        }
      ],
      "correct_answer": "A. Asherman syndrome",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Asherman syndrome</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Asherman syndrome is intra uterine adhesions, they arise due to: Surgical trauma to the uterus which may be seen following Dilatation and curettage (esp. sharp curettage) Cesarean section Myomectomy where the endometrial cavity is involved Metroplasty Trans-cervical resection of the endometrium Uterine artery embolization Endometrial ablative procedures Intra-uterine infections like tuberculosis and schistosomiasis</li><li>\u27a4 Asherman syndrome is intra uterine adhesions, they arise due to: Surgical trauma to the uterus which may be seen following Dilatation and curettage (esp. sharp curettage) Cesarean section Myomectomy where the endometrial cavity is involved Metroplasty Trans-cervical resection of the endometrium Uterine artery embolization Endometrial ablative procedures Intra-uterine infections like tuberculosis and schistosomiasis</li><li>\u27a4 Surgical trauma to the uterus which may be seen following Dilatation and curettage (esp. sharp curettage) Cesarean section Myomectomy where the endometrial cavity is involved Metroplasty Trans-cervical resection of the endometrium Uterine artery embolization Endometrial ablative procedures Intra-uterine infections like tuberculosis and schistosomiasis</li><li>\u27a4 Surgical trauma to the uterus which may be seen following Dilatation and curettage (esp. sharp curettage) Cesarean section Myomectomy where the endometrial cavity is involved Metroplasty Trans-cervical resection of the endometrium</li><li>\u27a4 Dilatation and curettage (esp. sharp curettage) Cesarean section Myomectomy where the endometrial cavity is involved Metroplasty Trans-cervical resection of the endometrium</li><li>\u27a4 Dilatation and curettage (esp. sharp curettage)</li><li>\u27a4 Cesarean section</li><li>\u27a4 Myomectomy where the endometrial cavity is involved</li><li>\u27a4 Metroplasty</li><li>\u27a4 Trans-cervical resection of the endometrium</li><li>\u27a4 Uterine artery embolization</li><li>\u27a4 Endometrial ablative procedures</li><li>\u27a4 Intra-uterine infections like tuberculosis and schistosomiasis</li><li>\u27a4 Symptoms: Hypomenorrhea Secondary amenorrhoea Secondary infertility Diagnosis On ultrasound</li><li>\u27a4 Symptoms: Hypomenorrhea Secondary amenorrhoea Secondary infertility</li><li>\u27a4 Hypomenorrhea Secondary amenorrhoea Secondary infertility</li><li>\u27a4 Hypomenorrhea</li><li>\u27a4 Secondary amenorrhoea</li><li>\u27a4 Secondary infertility</li><li>\u27a4 Diagnosis On ultrasound</li><li>\u27a4 On ultrasound</li><li>\u27a4 On ultrasound</li><li>\u27a4 Uterine cavity appears irregular/ i nterrupted; punctate echogenic foci in the endometrium/ indistinct endo-myometrial junction/ endometrial fluid: commonly loculated appearing as small focal cystic areas within the endometrium</li><li>\u27a4 Uterine cavity appears irregular/ i nterrupted; punctate echogenic foci in the endometrium/ indistinct endo-myometrial junction/ endometrial fluid: commonly loculated appearing as small focal cystic areas within the endometrium</li><li>\u27a4 On HSG Intra-uterine filling defects are seen giving a moth-eaten appearance Hysteroscopy Gold standard for diagnosis</li><li>\u27a4 On HSG Intra-uterine filling defects are seen giving a moth-eaten appearance</li><li>\u27a4 Intra-uterine filling defects are seen giving a moth-eaten appearance</li><li>\u27a4 Intra-uterine filling defects are seen giving a moth-eaten appearance</li><li>\u27a4 Hysteroscopy Gold standard for diagnosis</li><li>\u27a4 Gold standard for diagnosis</li><li>\u27a4 Gold standard for diagnosis</li><li>\u27a4 Treatment: Hysteroscopic adhesiolysis Post procedure: To stimulate endometrial proliferation and prevent reformation of adhesions, oral estrogen administration has proved effective. A cooper containing intra-uterine device can also be inserted to prevent reformation of adhesions Another hysteroscopy or HSG is typically performed at 3 months following the initial resection. Top of Form</li><li>\u27a4 Treatment: Hysteroscopic adhesiolysis Post procedure: To stimulate endometrial proliferation and prevent reformation of adhesions, oral estrogen administration has proved effective. A cooper containing intra-uterine device can also be inserted to prevent reformation of adhesions Another hysteroscopy or HSG is typically performed at 3 months following the initial resection. Top of Form</li><li>\u27a4 Hysteroscopic adhesiolysis Post procedure: To stimulate endometrial proliferation and prevent reformation of adhesions, oral estrogen administration has proved effective. A cooper containing intra-uterine device can also be inserted to prevent reformation of adhesions Another hysteroscopy or HSG is typically performed at 3 months following the initial resection. Top of Form</li><li>\u27a4 Hysteroscopic adhesiolysis</li><li>\u27a4 Post procedure: To stimulate endometrial proliferation and prevent reformation of adhesions, oral estrogen administration has proved effective. A cooper containing intra-uterine device can also be inserted to prevent reformation of adhesions Another hysteroscopy or HSG is typically performed at 3 months following the initial resection. Top of Form</li><li>\u27a4 To stimulate endometrial proliferation and prevent reformation of adhesions, oral estrogen administration has proved effective. A cooper containing intra-uterine device can also be inserted to prevent reformation of adhesions Another hysteroscopy or HSG is typically performed at 3 months following the initial resection. Top of Form</li><li>\u27a4 To stimulate endometrial proliferation and prevent reformation of adhesions, oral estrogen administration has proved effective. A cooper containing intra-uterine device can also be inserted to prevent reformation of adhesions</li><li>\u27a4 Another hysteroscopy or HSG is typically performed at 3 months following the initial resection. Top of Form</li><li>\u27a4 Ref: Speroff\u2019s 9 th edition chapter 10, amenorrhea</li><li>\u27a4 Ref: Speroff\u2019s 9 th edition chapter 10, amenorrhea</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1d7c2a04",
      "audio": ""
    },
    {
      "text": "An 18-year-old with previously regular menses, presents with amenorrhea. She is also diagnosed with anorexia nervosa. Which of the following is likely to be seen in this patient?",
      "options": [
        {
          "label": "A",
          "text": "Elevated luteinizing hormone (LH) level",
          "correct": false
        },
        {
          "label": "B",
          "text": "Elevated gonadotropin-releasing hormone (GnRH) level",
          "correct": false
        },
        {
          "label": "C",
          "text": "Elevated leptin level",
          "correct": false
        },
        {
          "label": "D",
          "text": "Elevated neuropeptide Y level",
          "correct": true
        }
      ],
      "correct_answer": "D. Elevated neuropeptide Y level",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Elevated neuropeptide Y level</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Ref: Page no 404, Williams Gynecology 3 rd edition</li><li>\u27a4 Ref: Page no 404, Williams Gynecology 3 rd edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c0957944",
      "audio": ""
    },
    {
      "text": "Which of the following statements is true regarding polycystic ovarian syndrome?",
      "options": [
        {
          "label": "A",
          "text": "Patients typically present with amenorrhea.",
          "correct": false
        },
        {
          "label": "B",
          "text": "It is the most common cause of chronic anovulation.",
          "correct": true
        },
        {
          "label": "C",
          "text": "It is characterized by hypogonadotropic hypogonadism.",
          "correct": false
        },
        {
          "label": "D",
          "text": "It is characterized by persistently elevated follicle stimulating hormone (FSH) and oestradiol levels",
          "correct": false
        }
      ],
      "correct_answer": "B. It is the most common cause of chronic anovulation.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. It is the most common cause of chronic anovulation.</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Ref: Page no 406, Williams Gynecology 3 rd edition</li><li>\u27a4 Ref: Page no 406, Williams Gynecology 3 rd edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "46963fe8",
      "audio": ""
    },
    {
      "text": "A 20-year-old girl presents to the OPD with excess facial hair for 6 months and delayed menstrual cycles. On evaluation, levels of free testosterone are increased. An ultrasound reveals normal uterus and normal ovaries on USG. The most likely diagnosis is?",
      "options": [
        {
          "label": "A",
          "text": "Adrenal hyperplasiaI",
          "correct": false
        },
        {
          "label": "B",
          "text": "Idiopathic hirsutism",
          "correct": false
        },
        {
          "label": "C",
          "text": "Polycystic Ovarian Syndrome",
          "correct": true
        },
        {
          "label": "D",
          "text": "Testosterone secreting tumor",
          "correct": false
        }
      ],
      "correct_answer": "C. Polycystic Ovarian Syndrome",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/27/picture9_0mgVKz8.jpg"
      ],
      "explanation": "<p><strong>Ans. C. Polycystic Ovarian Syndrome</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Polycystic ovarian syndrome/ disease (PCOS/PCOD) is a disorder of chronically abnormal ovarian function (oligo/anovulation) and hyperandrogenism frequently associated with hyperinsulinemia and insulin resistance, resulting in menstrual irregularity, infertility, and hirsutism. Rotterdam 2003 criteria is used to diagnose  PCOS/PCOD: As per this criterion, at least 2 of 3 should be present :</li><li>\u2022 Polycystic ovarian syndrome/ disease (PCOS/PCOD) is a disorder of chronically abnormal ovarian function (oligo/anovulation) and hyperandrogenism frequently associated with hyperinsulinemia and insulin resistance, resulting in menstrual irregularity, infertility, and hirsutism.</li><li>\u2022 Rotterdam 2003 criteria is used to diagnose  PCOS/PCOD: As per this criterion, at least 2 of 3 should be present :</li><li>\u2022 Rotterdam 2003 criteria is used to diagnose  PCOS/PCOD:</li><li>\u2022 Oligo/anovulation (causes oligomenorrhea, 2 0 amenorrhea, and infertility) Hyperandrogenism: Biochemical or clinical (increased serum androgens or acne, hirsutism) 12 or more than 12 follicle 2-9 mm in size present within 1 or both ovaries on USG and/or ovarian volume > 10 mL (pearl necklace pattern).</li><li>\u2022 Oligo/anovulation (causes oligomenorrhea, 2 0 amenorrhea, and infertility)</li><li>\u2022 Hyperandrogenism: Biochemical or clinical (increased serum androgens or acne, hirsutism)</li><li>\u2022 12 or more than 12 follicle 2-9 mm in size present within 1 or both ovaries on USG and/or ovarian volume > 10 mL (pearl necklace pattern).</li><li>\u2022 USG appearance of polycystic ovaries</li><li>\u2022 As the patient in the question satisfies first 2 criteria, she is a case of PCOS</li><li>\u2022 As the patient in the question satisfies first 2 criteria, she is a case of PCOS</li><li>\u2022 let's consider the other options:</li><li>\u2022 let's consider the other options:</li><li>\u2022 Option. A. Adrenal Hyperplasia : Adrenal hyperplasia, particularly congenital adrenal hyperplasia (CAH), can cause symptoms similar to PCOS, including hirsutism and menstrual irregularities, due to elevated androgens. However, it is usually diagnosed earlier in life and often has other associated adrenal hormone abnormalities.</li><li>\u2022 Option. A.</li><li>\u2022 Adrenal Hyperplasia</li><li>\u2022 Option. B. Idiopathic Hirsutism : Idiopathic hirsutism refers to hirsutism (excess hair growth) in the absence of any identifiable hormonal imbalance or ovarian/adrenal gland disorder. Given the increased free testosterone levels in this patient, idiopathic hirsutism is less likely.</li><li>\u2022 Option. B.</li><li>\u2022 Idiopathic Hirsutism</li><li>\u2022 Option. D. Testosterone Secreting Tumor : While a testosterone-secreting tumor can cause increased androgen levels and symptoms like hirsutism, these tumors are rare. The more common presentation of such tumors would include rapid onset of symptoms and markedly elevated testosterone levels.</li><li>\u2022 Option. D.</li><li>\u2022 Testosterone Secreting Tumor</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Ref: Page no 401, Speroff\u2019s Clinical Gynaecological endocrinology and infertility 9 th edition</li><li>\u27a4 Ref: Page no 401, Speroff\u2019s Clinical Gynaecological endocrinology and infertility 9 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b8d4d503",
      "audio": ""
    },
    {
      "text": "Which of the following is correct about polycystic ovarian disease (PCOD)? Testosterone> 2 ng/ml Infertility High FSH/LH ratio Fasting glucose/ insulin ratio > 4.5 Polycystic appearance on 1 or both ovaries on ultrasound",
      "options": [
        {
          "label": "A",
          "text": "a, b, c",
          "correct": false
        },
        {
          "label": "B",
          "text": "b, d, e",
          "correct": false
        },
        {
          "label": "C",
          "text": "a, b, e",
          "correct": true
        },
        {
          "label": "D",
          "text": "b, c, d",
          "correct": false
        }
      ],
      "correct_answer": "C. a, b, e",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. a, b, e</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Ref: Page no 411, Speroff\u2019s clinical gynaecological endocrinology and infertility 9 th edition</li><li>\u27a4 Ref: Page no 411, Speroff\u2019s clinical gynaecological endocrinology and infertility 9 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "24dfd3b7",
      "audio": ""
    },
    {
      "text": "The biochemical chaanges in established cases of Stein-Leventhal syndrome are all except?",
      "options": [
        {
          "label": "A",
          "text": "Marked elevation of LH in contrast to FSH",
          "correct": false
        },
        {
          "label": "B",
          "text": "Insulin resistance",
          "correct": false
        },
        {
          "label": "C",
          "text": "Elevation of plasma testosterone",
          "correct": false
        },
        {
          "label": "D",
          "text": "Elevation in the levels of sex hormone binding globulin (SHBG)",
          "correct": true
        }
      ],
      "correct_answer": "D. Elevation in the levels of sex hormone binding globulin (SHBG)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Elevation in the levels of sex hormone binding globulin (SHBG)</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Ref: Page 411 Speroff\u2019s Clinical Gynaecological endocrinology and infertility 9 th edition</li><li>\u27a4 Ref: Page 411 Speroff\u2019s Clinical Gynaecological endocrinology and infertility 9 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "524f2cd8",
      "audio": ""
    },
    {
      "text": "Which of the following is the most likely diagnosis in a 28-year-old obese woman presenting with Oligomenorrhea, infertility and hirsutism?",
      "options": [
        {
          "label": "A",
          "text": "Polycystic ovaries",
          "correct": true
        },
        {
          "label": "B",
          "text": "Endometriosis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Pelvic inflammatory disease",
          "correct": false
        },
        {
          "label": "D",
          "text": "Cushing syndrome",
          "correct": false
        }
      ],
      "correct_answer": "A. Polycystic ovaries",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Polycystic ovaries</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Ref: Page 400, Speroff\u2019s clinical Gynaecological endocrinology and infertility 9 th edition</li><li>\u27a4 Ref: Page 400, Speroff\u2019s clinical Gynaecological endocrinology and infertility 9 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e2ba2287",
      "audio": ""
    },
    {
      "text": "Preeti, a 20-year-old girl presents with a history of rapidly developing hirsutism, severe acne and amenorrhea. Her BMI is 19. To establish the diagnosis, which would be the most appropriate blood test?",
      "options": [
        {
          "label": "A",
          "text": "17-OH progesterone",
          "correct": false
        },
        {
          "label": "B",
          "text": "DHEA",
          "correct": false
        },
        {
          "label": "C",
          "text": "Testosterone",
          "correct": true
        },
        {
          "label": "D",
          "text": "LH: FSH ratio",
          "correct": false
        }
      ],
      "correct_answer": "C. Testosterone",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Testosterone</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Ref: Page 449, Speroff\u2019s clinical gynecological endocrinology and infertility 9 th edition</li><li>\u27a4 Ref: Page 449, Speroff\u2019s clinical gynecological endocrinology and infertility 9 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "be02a63f",
      "audio": ""
    },
    {
      "text": "Which of the following is not included in Rotterdam criteria?",
      "options": [
        {
          "label": "A",
          "text": "Oligomenorrhea",
          "correct": false
        },
        {
          "label": "B",
          "text": "Sonographic polycystic appearance of ovaries",
          "correct": false
        },
        {
          "label": "C",
          "text": "Peripheral distribution of follicles on transvaginal ultrasonography",
          "correct": true
        },
        {
          "label": "D",
          "text": "Clinical signs of hyperandrogenism",
          "correct": false
        }
      ],
      "correct_answer": "C. Peripheral distribution of follicles on transvaginal ultrasonography",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Peripheral distribution of follicles on transvaginal ultrasonography</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Ref: Page 400, Speroff\u2019s clinical gynecological endocrinology and infertility 9 th edition</li><li>\u27a4 Ref: Page 400, Speroff\u2019s clinical gynecological endocrinology and infertility 9 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1361851e",
      "audio": ""
    },
    {
      "text": "A 19y girl with PCOS is started on the combination pill shown below. What is the role of the progesterone component of this combination?",
      "options": [
        {
          "label": "A",
          "text": "Increases LH production",
          "correct": false
        },
        {
          "label": "B",
          "text": "Reduces production of FSH",
          "correct": false
        },
        {
          "label": "C",
          "text": "Acts on androgen receptors and antagonizes it",
          "correct": false
        },
        {
          "label": "D",
          "text": "Reduces ovarian androgen production",
          "correct": true
        }
      ],
      "correct_answer": "D. Reduces ovarian androgen production",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/27/picture10.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Reduces ovarian androgen production</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3922b414",
      "audio": ""
    },
    {
      "text": "All of the following features are seen in PCOS except?",
      "options": [
        {
          "label": "A",
          "text": "Androgenic alopecia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Increased facial hair",
          "correct": false
        },
        {
          "label": "C",
          "text": "Clitoromegaly",
          "correct": true
        },
        {
          "label": "D",
          "text": "Acne",
          "correct": false
        }
      ],
      "correct_answer": "C. Clitoromegaly",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Clitoromegaly</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Ref: Page 449, Speroff\u2019s Clinical Gynaecological Endocrinology and infertility 9 th edition</li><li>\u27a4 Ref: Page 449, Speroff\u2019s Clinical Gynaecological Endocrinology and infertility 9 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b9f0808d",
      "audio": ""
    },
    {
      "text": "During evaluation of PCOS, a serum 17 \u2013hydroxyprogesterone levels of 800 ng/dl was obtained. This value warrants the exclusion of?",
      "options": [
        {
          "label": "A",
          "text": "Insulin resistance",
          "correct": false
        },
        {
          "label": "B",
          "text": "Cushing syndrome",
          "correct": false
        },
        {
          "label": "C",
          "text": "Androgen producing tumors",
          "correct": false
        },
        {
          "label": "D",
          "text": "Congenital adrenal hyperplasia",
          "correct": true
        }
      ],
      "correct_answer": "D. Congenital adrenal hyperplasia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Congenital adrenal hyperplasia</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Ref: Page 449, Speroff\u2019s clinical gynecological endocrinology and infertility 9 th edition</li><li>\u27a4 Ref: Page 449, Speroff\u2019s clinical gynecological endocrinology and infertility 9 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "db782e44",
      "audio": ""
    },
    {
      "text": "A 19-year-old girl with a long-standing history of irregular menstrual cycles and amenorrhea presents with an ultrasound picture shown below. Which of the following is least likely to be seen in her?",
      "options": [
        {
          "label": "A",
          "text": "Male pattern hair growth on lower abdomen",
          "correct": false
        },
        {
          "label": "B",
          "text": "Thickened dark skin on inner thighs",
          "correct": false
        },
        {
          "label": "C",
          "text": "Abnormal glucose tolerance test results",
          "correct": false
        },
        {
          "label": "D",
          "text": "High serum levels of high-density lipoproteins",
          "correct": true
        }
      ],
      "correct_answer": "D. High serum levels of high-density lipoproteins",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/27/picture11_c5RSZPQ.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D.\u00a0 High serum levels of high-density lipoproteins</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Ref: Page 400, Speroff\u2019s clinical gynecological endocrinology and infertility 9 th edition</li><li>\u27a4 Ref: Page 400, Speroff\u2019s clinical gynecological endocrinology and infertility 9 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "45e4637e",
      "audio": ""
    },
    {
      "text": "During detailed workup of PCOD in a 19-year-old patient shown below is noted to have a serum total testosterone level of 375 ng/dl with rapidly increasing hirsutism. Which of the following endocrine glands is likely to harbour the androgen producing tumour?",
      "options": [
        {
          "label": "A",
          "text": "Pancreas",
          "correct": false
        },
        {
          "label": "B",
          "text": "Adrenal",
          "correct": false
        },
        {
          "label": "C",
          "text": "Ovary",
          "correct": true
        },
        {
          "label": "D",
          "text": "Pituitary",
          "correct": false
        }
      ],
      "correct_answer": "C. Ovary",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/27/picture12_CA3vfPf.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C.\u00a0 Ovary</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Ref: Page 449, Speroff\u2019s Clinical Gynaecological endocrinology and infertility 9 th edition</li><li>\u27a4 Ref: Page 449, Speroff\u2019s Clinical Gynaecological endocrinology and infertility 9 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8c3b3b1a",
      "audio": ""
    },
    {
      "text": "Match the following correctly:",
      "options": [
        {
          "label": "A",
          "text": "1b 2d 3c 4a",
          "correct": false
        },
        {
          "label": "B",
          "text": "1a 2d 3c 4b",
          "correct": true
        },
        {
          "label": "C",
          "text": "1a 2c 3d 4b",
          "correct": false
        },
        {
          "label": "D",
          "text": "1b 2c 3d 4a",
          "correct": false
        }
      ],
      "correct_answer": "B. 1a 2d 3c 4b",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/24/screenshot-2024-04-24-113312.JPG"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/24/screenshot-2024-04-24-113640.JPG",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/24/screenshot-2024-04-24-113640_kvczIXj.JPG"
      ],
      "explanation": "<p><strong>Ans. B. 1a 2d 3c 4b</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Remember this very important table</li><li>\u2022 Remember this very important table</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Remember this very important table</li><li>\u27a4 Remember this very important table</li><li>\u27a4 Ref: DC Dutta\u2019s Textbook of Contraception</li><li>\u27a4 Ref: DC Dutta\u2019s Textbook of Contraception</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a0155094",
      "audio": ""
    },
    {
      "text": "Presence of the SRY gene will cause what important development in embryology?",
      "options": [
        {
          "label": "A",
          "text": "Disappearance of the Mullerian duct",
          "correct": false
        },
        {
          "label": "B",
          "text": "Differentiation of the Wolffian duct",
          "correct": false
        },
        {
          "label": "C",
          "text": "Differentiation of the gonad into the testes",
          "correct": true
        },
        {
          "label": "D",
          "text": "Disappearance of the ovary",
          "correct": false
        }
      ],
      "correct_answer": "C. Differentiation of the gonad into the testes",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Differentiation of the gonad into the testes</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Normal Sex Development</li><li>\u2022 Normal Sex Development</li><li>\u2022 Sex development starts in utero and continues in adult life with attainment of sexual maturity and reproductive capability Major determinants of sex development are Chromosomal Sex (46XX or 46XY) Gonadal sex (Testes or ovary) Phenotypic sex (External genitalia) Sex determination primarily begins by the presence or absence of the Y chromosome On the Short arm of the Y chromosome, there is located the SRY gene (Sex Determining Region) \u2013 Yp11.3 and is the most important genetic aspect for sex determination and its presence or absence determines the direction of gonadal differentiation. SRY activates several other genes that promote testis development. These include SOX 9 Fgf 9 In 46 XX embryos, genes responsible include Wnt4 and Rspo 1. The chromosomal sex determines the gonadal sex (i.e. whether the gonads will become testes or ovaries) in the embryo. The gonads are BIPOTENT (Undifferentiated) till 5 weeks, they then differentiate into testes or ovaries based on whether the karyotype is 46XX or 46XY</li><li>\u2022 Sex development starts in utero and continues in adult life with attainment of sexual maturity and reproductive capability</li><li>\u2022 Major determinants of sex development are Chromosomal Sex (46XX or 46XY) Gonadal sex (Testes or ovary) Phenotypic sex (External genitalia)</li><li>\u2022 Chromosomal Sex (46XX or 46XY) Gonadal sex (Testes or ovary) Phenotypic sex (External genitalia)</li><li>\u2022 Chromosomal Sex (46XX or 46XY)</li><li>\u2022 Gonadal sex (Testes or ovary)</li><li>\u2022 Phenotypic sex (External genitalia)</li><li>\u2022 Sex determination primarily begins by the presence or absence of the Y chromosome</li><li>\u2022 On the Short arm of the Y chromosome, there is located the SRY gene (Sex Determining Region) \u2013 Yp11.3 and is the most important genetic aspect for sex determination and its presence or absence determines the direction of gonadal differentiation.</li><li>\u2022 On the Short arm of the Y chromosome, there is located the SRY gene (Sex Determining Region) \u2013 Yp11.3 and is the most important genetic aspect for sex determination and its presence or absence determines the direction of gonadal differentiation.</li><li>\u2022 SRY activates several other genes that promote testis development. These include SOX 9 Fgf 9</li><li>\u2022 SOX 9 Fgf 9</li><li>\u2022 SOX 9</li><li>\u2022 Fgf 9</li><li>\u2022 In 46 XX embryos, genes responsible include Wnt4 and Rspo 1.</li><li>\u2022 The chromosomal sex determines the gonadal sex (i.e. whether the gonads will become testes or ovaries) in the embryo.</li><li>\u2022 The gonads are BIPOTENT (Undifferentiated) till 5 weeks, they then differentiate into testes or ovaries based on whether the karyotype is 46XX or 46XY</li><li>\u2022 The gonads are BIPOTENT (Undifferentiated) till 5 weeks, they then differentiate into testes or ovaries based on whether the karyotype is 46XX or 46XY</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 On the Short arm of the Y chromosome, there is located the SRY gene (Sex Determining Region) \u2013 Yp11.3 and is the most important genetic aspect for sex determination and its presence or absence determines the direction of gonadal differentiation. SRY activates several other genes that promote testis development.</li><li>\u27a4 On the Short arm of the Y chromosome, there is located the SRY gene (Sex Determining Region) \u2013 Yp11.3 and is the most important genetic aspect for sex determination and its presence or absence determines the direction of gonadal differentiation.</li><li>\u27a4 SRY activates several other genes that promote testis development.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f4b284ec",
      "audio": ""
    },
    {
      "text": "A curious pregnant patient visits the antenatal OPD. She has missed her period by 4 days and her pregnancy test is positive. This is her 1 st pregnancy and although, sex detection is banned in India, she is very curious about how the baby forms and asks if it is possible to know the sex of the baby now. You tell her that the gonads are undifferentiated at present. The gonads are bipotent till?",
      "options": [
        {
          "label": "A",
          "text": "5 weeks",
          "correct": true
        },
        {
          "label": "B",
          "text": "6 weeks",
          "correct": false
        },
        {
          "label": "C",
          "text": "7 weeks",
          "correct": false
        },
        {
          "label": "D",
          "text": "8 weeks",
          "correct": false
        }
      ],
      "correct_answer": "A. 5 weeks",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/24/screenshot-2024-04-24-113705.JPG"
      ],
      "explanation": "<p><strong>Ans. A. 5 weeks</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 The gonads are BIPOTENT (Undifferentiated) till 5 weeks, they then differentiate into testes or ovaries based on whether the karyotype is 46XX or 46XY</li><li>\u2022 The gonads are BIPOTENT (Undifferentiated) till 5 weeks, they then differentiate into testes or ovaries based on whether the karyotype is 46XX or 46XY</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "606eb05c",
      "audio": ""
    },
    {
      "text": "Swyer syndrome is an example of",
      "options": [
        {
          "label": "A",
          "text": "45 XO gonadal dysgenesis",
          "correct": false
        },
        {
          "label": "B",
          "text": "46 XX gonadal dysgeneses",
          "correct": false
        },
        {
          "label": "C",
          "text": "46 XY gonadal dysgenesis",
          "correct": true
        },
        {
          "label": "D",
          "text": "46 XXY gonadal dysgenesis",
          "correct": false
        }
      ],
      "correct_answer": "C. 46 XY gonadal dysgenesis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. 46 XY gonadal dysgenesis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 46 XY Complete gonadal dysgenesis (Swyer syndrome)</li><li>\u2022 46 XY Complete gonadal dysgenesis (Swyer syndrome)</li><li>\u2022 Uncommon form of gonadal dysgenesis; 46XY karyotype The dysgenetic gonads don\u2019t produce AMH/ Androgens, so Phenotype is female. They have a normal uterus, fallopian tubes, cervix and vagina No masculinization of external genitalia 15% mutation of SRY gene Majority: No cause identified Present as Primary amenorrhoea Delayed sexual maturation Normal pubic hair Normal female internal and external genitalia Diagnosis: Hypogonadotrophic hypogonadism Karyotype Treatment Sex of assignment and rearing: Female Gonadectomy soon after diagnosis Estrogen: to maintain sexual maturation and breast development Pregnancy can be achieved with IVF with donor oocytes</li><li>\u2022 Uncommon form of gonadal dysgenesis; 46XY karyotype</li><li>\u2022 The dysgenetic gonads don\u2019t produce AMH/ Androgens, so Phenotype is female.</li><li>\u2022 They have a normal uterus, fallopian tubes, cervix and vagina</li><li>\u2022 No masculinization of external genitalia</li><li>\u2022 15% mutation of SRY gene</li><li>\u2022 Majority: No cause identified</li><li>\u2022 Present as Primary amenorrhoea Delayed sexual maturation Normal pubic hair Normal female internal and external genitalia</li><li>\u2022 Primary amenorrhoea Delayed sexual maturation Normal pubic hair Normal female internal and external genitalia</li><li>\u2022 Primary amenorrhoea</li><li>\u2022 Delayed sexual maturation</li><li>\u2022 Normal pubic hair</li><li>\u2022 Normal female internal and external genitalia</li><li>\u2022 Diagnosis: Hypogonadotrophic hypogonadism Karyotype</li><li>\u2022 Hypogonadotrophic hypogonadism Karyotype</li><li>\u2022 Hypogonadotrophic hypogonadism</li><li>\u2022 Karyotype</li><li>\u2022 Treatment</li><li>\u2022 Sex of assignment and rearing: Female</li><li>\u2022 Gonadectomy soon after diagnosis</li><li>\u2022 Estrogen: to maintain sexual maturation and breast development</li><li>\u2022 Pregnancy can be achieved with IVF with donor oocytes</li><li>\u2022 Other options:</li><li>\u2022 Other options:</li><li>\u2022 Option A: 45 XO gonadal dysgenesis: This is Turner syndrome Option B: 46 XX gonadal dysgenesis: There is no particular name but it includes ovarian dysgenesis leading to hypergonadotropic hypogonadism Option D: 46 XXY gonadal dysgenesis: This is Klinefelter syndrome</li><li>\u2022 Option A: 45 XO gonadal dysgenesis: This is Turner syndrome</li><li>\u2022 Option A: 45 XO gonadal dysgenesis:</li><li>\u2022 Option B: 46 XX gonadal dysgenesis: There is no particular name but it includes ovarian dysgenesis leading to hypergonadotropic hypogonadism</li><li>\u2022 Option B: 46 XX gonadal dysgenesis:</li><li>\u2022 Option D: 46 XXY gonadal dysgenesis: This is Klinefelter syndrome</li><li>\u2022 Option D: 46 XXY gonadal dysgenesis:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 46 XY complete gonadal dysgenesis is Swyer syndrome</li><li>\u27a4 46 XY complete gonadal dysgenesis is Swyer syndrome</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "bf2b736d",
      "audio": ""
    },
    {
      "text": "A 14-year-old girl is brought to the OPD by her mother. She is of normal height, at the top of her class but her mother is concerned because of a sudden increase in hair growth and hoarseness of voice. She also mentions that she hasn\u2019t yet attained menarche. On examination, there is absent breast development and minimal presence of pubic and axillary hair. There is also increased facial hair growth and on local examination, there is an enlarged clitoris. An ultrasound reveals an absent uterus with the presence of gonad-like structures in the inguinal canal. Suspecting 5 alpha reductase deficiency, testosterone and DHT level is done. What is the expected finding in 5 alpha reductase deficiency?",
      "options": [
        {
          "label": "A",
          "text": "Increased testosterone/ DHT ratio",
          "correct": true
        },
        {
          "label": "B",
          "text": "Decreased testosterone/ DHT ratio",
          "correct": false
        },
        {
          "label": "C",
          "text": "No change in the testosterone/ DHT ratio",
          "correct": false
        },
        {
          "label": "D",
          "text": "Absent testosterone levels",
          "correct": false
        }
      ],
      "correct_answer": "A. Increased testosterone/ DHT ratio",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Increased testosterone/ DHT ratio</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 5 \u03b1 Reductase Deficiency</li><li>\u2022 5</li><li>\u2022 \u03b1</li><li>\u2022 Reductase Deficiency</li><li>\u2022 Autosomal recessive Karyotype: 46XY Defective conversion of Testosterone to DHT (which is mediated by the enzyme 5 alpha reductase) Testosterone (in fetal life): causes development of the internal male genitalia DHT is responsible for external male genital development: Hence this does not develop as the enzyme mediating the conversion is absent/ deficient Classical presentation: External genitalia: predominantly Female at birth Internal genitalia: Male (The epididymis, the vas deferens, seminal vesicles and ejaculatory ducts form but empty into a short blind vagina) Testis: Located in the inguinal canal At Puberty: Virilization of varying degrees Affected men develop a normal muscle mass, libido, deepening of voice (Testosterone dependent) but have less body hair, less temporal hairline recession, no acne (All these are DHT dependent) Diagnosis: Suspect in infants with genital ambiguity Suspect in adolescence with the characteristic phenotype and a serum hormonal profile showing normal male level testosterone and an increased testosterone/ DHT ratio</li><li>\u2022 Autosomal recessive</li><li>\u2022 Karyotype: 46XY</li><li>\u2022 Defective conversion of Testosterone to DHT (which is mediated by the enzyme 5 alpha reductase)</li><li>\u2022 Testosterone (in fetal life): causes development of the internal male genitalia</li><li>\u2022 DHT is responsible for external male genital development: Hence this does not develop as the enzyme mediating the conversion is absent/ deficient</li><li>\u2022 Classical presentation: External genitalia: predominantly Female at birth Internal genitalia: Male (The epididymis, the vas deferens, seminal vesicles and ejaculatory ducts form but empty into a short blind vagina) Testis: Located in the inguinal canal At Puberty: Virilization of varying degrees Affected men develop a normal muscle mass, libido, deepening of voice (Testosterone dependent) but have less body hair, less temporal hairline recession, no acne (All these are DHT dependent)</li><li>\u2022 Classical presentation:</li><li>\u2022 External genitalia: predominantly Female at birth Internal genitalia: Male (The epididymis, the vas deferens, seminal vesicles and ejaculatory ducts form but empty into a short blind vagina) Testis: Located in the inguinal canal At Puberty: Virilization of varying degrees Affected men develop a normal muscle mass, libido, deepening of voice (Testosterone dependent) but have less body hair, less temporal hairline recession, no acne (All these are DHT dependent)</li><li>\u2022 External genitalia: predominantly Female at birth</li><li>\u2022 Internal genitalia: Male (The epididymis, the vas deferens, seminal vesicles and ejaculatory ducts form but empty into a short blind vagina)</li><li>\u2022 Testis: Located in the inguinal canal</li><li>\u2022 At Puberty: Virilization of varying degrees</li><li>\u2022 Affected men develop a normal muscle mass, libido, deepening of voice (Testosterone dependent) but have less body hair, less temporal hairline recession, no acne (All these are DHT dependent)</li><li>\u2022 Diagnosis: Suspect in infants with genital ambiguity Suspect in adolescence with the characteristic phenotype and a serum hormonal profile showing normal male level testosterone and an increased testosterone/ DHT ratio</li><li>\u2022 Diagnosis:</li><li>\u2022 Suspect in infants with genital ambiguity Suspect in adolescence with the characteristic phenotype and a serum hormonal profile showing normal male level testosterone and an increased testosterone/ DHT ratio</li><li>\u2022 Suspect in infants with genital ambiguity</li><li>\u2022 Suspect in adolescence with the characteristic phenotype and a serum hormonal profile showing normal male level testosterone and an increased testosterone/ DHT ratio</li><li>\u2022 normal male level testosterone and an increased testosterone/ DHT ratio</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e9502de9",
      "audio": ""
    },
    {
      "text": "A 45-year old presents for a routine gynecological checkup. She is having regular cycles with normal flow and mild dysmenorrhea on the 1 st day. She is a non-smoker and has no history of hypertension or diabetes. Her last pap smear was 2 years back which was reported to be normal. An ultrasound shows the presence of a 4 x 4 cm intramural fibroid with a sub-serosal component. She is very anxious and seeks your opinion on what should be done.",
      "options": [
        {
          "label": "A",
          "text": "GnRH agonists",
          "correct": false
        },
        {
          "label": "B",
          "text": "Laparoscopic hysterectomy",
          "correct": false
        },
        {
          "label": "C",
          "text": "Laparoscopic myomectomy",
          "correct": false
        },
        {
          "label": "D",
          "text": "Review ultrasound after 1 year",
          "correct": true
        }
      ],
      "correct_answer": "D. Review ultrasound after 1 year",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Review ultrasound after 1 year</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 This is an asymptomatic fibroid Asymptomatic fibroids (irrespective of size) do not require treatment and just need an annual evaluation. Symptomatic fibroids can be managed medically/ surgically/ non invasive techniques based on several factors like the age of the patient, the size and number of fibroids and the location of fibroid</li><li>\u2022 This is an asymptomatic fibroid</li><li>\u2022 Asymptomatic fibroids (irrespective of size) do not require treatment and just need an annual evaluation.</li><li>\u2022 Symptomatic fibroids can be managed medically/ surgically/ non invasive techniques based on several factors like the age of the patient, the size and number of fibroids and the location of fibroid</li><li>\u2022 Other Options</li><li>\u2022 Other Options</li><li>\u2022 Option A: GnRH agonists: This can be given to women with symptomatic fibroids to reduce the size and also control symptoms. It is also given to women pre-operatively to reduce the size of the fibroid Option B: Laparoscopic hysterectomy: There is no indication for surgical managment in a patient with an asymptomatic fibroid. Following menopause, fibroids usually shrink in size due to hypo-estrogenism. Option C: Laparoscopic myomectomy: There is no indication for doing a myomectomy in a patient with an asymptomatic fibroid.</li><li>\u2022 Option A: GnRH agonists: This can be given to women with symptomatic fibroids to reduce the size and also control symptoms. It is also given to women pre-operatively to reduce the size of the fibroid</li><li>\u2022 Option A:</li><li>\u2022 Option B: Laparoscopic hysterectomy: There is no indication for surgical managment in a patient with an asymptomatic fibroid. Following menopause, fibroids usually shrink in size due to hypo-estrogenism.</li><li>\u2022 Option B:</li><li>\u2022 Option C: Laparoscopic myomectomy: There is no indication for doing a myomectomy in a patient with an asymptomatic fibroid.</li><li>\u2022 Option C:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Management of symotomatic fibroids can be medical or surgical or newer non invasive techniques</li><li>\u27a4 Management of symotomatic fibroids can be medical or surgical or newer non invasive techniques</li><li>\u27a4 1. Medical Management</li><li>\u27a4 Non Hormonal: NSAIDs for pain and heavy bleeding Anti-fibrinolytics (Tranexamic acid): For heavy bleeding Hormonal Combined OCPS SPRMs Ulipristal acetate Mifepristone LNG-IUS: in small fibroids NOT distorting the uterine cavity GnRH agonists GnRH antagonists</li><li>\u27a4 Non Hormonal: NSAIDs for pain and heavy bleeding Anti-fibrinolytics (Tranexamic acid): For heavy bleeding</li><li>\u27a4 NSAIDs for pain and heavy bleeding Anti-fibrinolytics (Tranexamic acid): For heavy bleeding</li><li>\u27a4 NSAIDs for pain and heavy bleeding</li><li>\u27a4 Anti-fibrinolytics (Tranexamic acid): For heavy bleeding</li><li>\u27a4 Hormonal Combined OCPS SPRMs Ulipristal acetate Mifepristone LNG-IUS: in small fibroids NOT distorting the uterine cavity GnRH agonists GnRH antagonists</li><li>\u27a4 Combined OCPS SPRMs Ulipristal acetate Mifepristone LNG-IUS: in small fibroids NOT distorting the uterine cavity GnRH agonists GnRH antagonists</li><li>\u27a4 Combined OCPS</li><li>\u27a4 SPRMs Ulipristal acetate Mifepristone</li><li>\u27a4 Ulipristal acetate Mifepristone</li><li>\u27a4 Ulipristal acetate</li><li>\u27a4 Mifepristone</li><li>\u27a4 LNG-IUS: in small fibroids NOT distorting the uterine cavity</li><li>\u27a4 GnRH agonists</li><li>\u27a4 GnRH antagonists</li><li>\u27a4 2. Surgical Management</li><li>\u27a4 a. Myomectomy (Laparoscopic/ Laparotomy/ Hysteroscopic for submucous myomas)</li><li>\u27a4 b. Hysterectomy: Preferred in women who are not wanting future fertility with large/ multiple symptomatic fibroids</li><li>\u27a4 3. Non invasive</li><li>\u27a4 a. Magnetic Resonance Guided Focused Ultrasound (MRgFUS)</li><li>\u27a4 b. Uterine artery embolization</li><li>\u27a4 *Asymptomatic fibroids (irrespective of size) do not require treatment and just need an annual evaluation.</li><li>\u27a4 *Asymptomatic fibroids (irrespective of size) do not require treatment and just need an annual evaluation.</li><li>\u27a4 Ref: Page no 232, DC Dutta\u2019s textbook of gynecology, 8 th edition</li><li>\u27a4 Ref: Page no 232, DC Dutta\u2019s textbook of gynecology, 8 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "86b52a7e",
      "audio": ""
    },
    {
      "text": "A 23-year primi is presents at 16 weeks pregnancy with acute abdominal pain. On examination, the uterus is 20 weeks size and there is tenderness over the abdomen. An ultrasound reveals, a 6 cm fibroid in the anterior wall. What is the next best management?",
      "options": [
        {
          "label": "A",
          "text": "Advise MTP",
          "correct": false
        },
        {
          "label": "B",
          "text": "Laparoscopic myomectomy",
          "correct": false
        },
        {
          "label": "C",
          "text": "Analgesia and hydration",
          "correct": true
        },
        {
          "label": "D",
          "text": "Hysterotomy and myomectomy",
          "correct": false
        }
      ],
      "correct_answer": "C. Analgesia and hydration",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Analgesia and hydration</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 This is most likely a red degeneration of fibroid which is commonly seen in pregnancy. Red degeneration occurs in a large fibroid mainly during 2 nd half of pregnancy and puerperium. Pain is the predominant symptom. Treatment is supportive and pain usually settles with analgesics and anti-inflammatory drugs</li><li>\u2022 This is most likely a red degeneration of fibroid which is commonly seen in pregnancy.</li><li>\u2022 Red degeneration occurs in a large fibroid mainly during 2 nd half of pregnancy and puerperium.</li><li>\u2022 Pain is the predominant symptom.</li><li>\u2022 Treatment is supportive and pain usually settles with analgesics and anti-inflammatory drugs</li><li>\u2022 Other Options</li><li>\u2022 Option A: Advise MTP: This is usually never advised in red degeneration as majority of red degenerations will symotomatically improve Option B: Laparoscopic myomectomy: Not indicated during pregnancy Option C: Hysterotomy and myomectomy: Nor indicated in red degeneration of fibroid</li><li>\u2022 Option A: Advise MTP: This is usually never advised in red degeneration as majority of red degenerations will symotomatically improve</li><li>\u2022 Option B: Laparoscopic myomectomy: Not indicated during pregnancy</li><li>\u2022 Option C: Hysterotomy and myomectomy: Nor indicated in red degeneration of fibroid</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Red degeneration occurs in a large fibroid mainly during 2 nd half of pregnancy and puerperium. Pain is the predominant symptom. Treatment is supportive and pain usually settles with analgesics and anti-inflammatory drugs</li><li>\u27a4 Red degeneration occurs in a large fibroid mainly during 2 nd half of pregnancy and puerperium.</li><li>\u27a4 Pain is the predominant symptom.</li><li>\u27a4 Treatment is supportive and pain usually settles with analgesics and anti-inflammatory drugs</li><li>\u27a4 Ref: Page no 227, DC Dutta\u2019s Textbook of gynecology</li><li>\u27a4 Ref: Page no 227, DC Dutta\u2019s Textbook of gynecology</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c847c9ff",
      "audio": ""
    },
    {
      "text": "The most common degeneration seen in uterine fibroids is",
      "options": [
        {
          "label": "A",
          "text": "Calcific degeneration",
          "correct": false
        },
        {
          "label": "B",
          "text": "Fatty degeneration",
          "correct": false
        },
        {
          "label": "C",
          "text": "Hyaline degeneration",
          "correct": true
        },
        {
          "label": "D",
          "text": "Red degeneration",
          "correct": false
        }
      ],
      "correct_answer": "C. Hyaline degeneration",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Hyaline degeneration</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 The most common type of degeneration in fibroids is hyaline degeneration</li><li>\u2022 The most common type of degeneration in fibroids is hyaline degeneration</li><li>\u2022 Red degeneration, calcific degeneration and fatty degeneration are other kinds of degeneration in fibroids</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The most common type of degeneration in fibroids is hyaline degeneration</li><li>\u27a4 The most common type of degeneration in fibroids is hyaline degeneration</li><li>\u27a4 Ref: Page no 227, DC Dutta\u2019s Textbook of gynecology</li><li>\u27a4 Ref: Page no 227, DC Dutta\u2019s Textbook of gynecology</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "649ff5aa",
      "audio": ""
    },
    {
      "text": "A 34-year nulliparous woman presents to the OPD. She complains of pelvic heaviness. She also mentions that her periods have been increasingly heavy in amount and she has to take a pain killer on the 1 st 2 days of her period due to excessive pain. The periods are otherwise regular. On examination, there is an irregular mass palpated abdominally which is about the size of an 18 weeks gravid uterus. On bimanual exam, the same irregular mass is felt and there is transmitted mobility. What is the possible diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Adenomyosis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Fibroid polyp",
          "correct": false
        },
        {
          "label": "C",
          "text": "Leiomyoma",
          "correct": true
        },
        {
          "label": "D",
          "text": "Ovarian mass",
          "correct": false
        }
      ],
      "correct_answer": "C. Leiomyoma",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Leiomyoma</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 This patient has symptoms of heavy menstrual bleed and dysmenorrhea which are seen in adenomyosis, fibroids (leiomyoma) and polyp. On examination, this is  a fibroid (probably multiple fibroids) The uterus is significantly enlarged and irregular There is transmitted mobility i.e. the mass is arising from the uterus (transmitted mobility is absent in ovarian masses) The woman is nulliparous</li><li>\u2022 This patient has symptoms of heavy menstrual bleed and dysmenorrhea which are seen in adenomyosis, fibroids (leiomyoma) and polyp.</li><li>\u2022 On examination, this is  a fibroid (probably multiple fibroids) The uterus is significantly enlarged and irregular There is transmitted mobility i.e. the mass is arising from the uterus (transmitted mobility is absent in ovarian masses) The woman is nulliparous</li><li>\u2022 The uterus is significantly enlarged and irregular There is transmitted mobility i.e. the mass is arising from the uterus (transmitted mobility is absent in ovarian masses) The woman is nulliparous</li><li>\u2022 The uterus is significantly enlarged and irregular</li><li>\u2022 There is transmitted mobility i.e. the mass is arising from the uterus (transmitted mobility is absent in ovarian masses)</li><li>\u2022 The woman is nulliparous</li><li>\u2022 Other Options:</li><li>\u2022 Other Options:</li><li>\u2022 In adenomyosis, the uterus is regularly enlarged (max size of 12-14 weeks size) In fibroid polyp, the uterus will be normal or slightly enlarged in size and on speculum exam, a polyp may be seen extruding from the os. Fibroid polyps usually present with inter menstrual bleeding or irregular bleeding In ovarian mass, there usually won't be any menstrual symptoms, also transmitted mobility will be absent (i.e. on moving the mass, the cervix will not be felt to move)</li><li>\u2022 In adenomyosis, the uterus is regularly enlarged (max size of 12-14 weeks size)</li><li>\u2022 In fibroid polyp, the uterus will be normal or slightly enlarged in size and on speculum exam, a polyp may be seen extruding from the os. Fibroid polyps usually present with inter menstrual bleeding or irregular bleeding</li><li>\u2022 In ovarian mass, there usually won't be any menstrual symptoms, also transmitted mobility will be absent (i.e. on moving the mass, the cervix will not be felt to move)</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 C/f of fibroid uterus</li><li>\u27a4 C/f of fibroid uterus</li><li>\u27a4 Symptoms</li><li>\u27a4 Symptoms</li><li>\u27a4 Menorrhagia Dysmenorrhoea Infertility Abdominal mass and pressure symptoms</li><li>\u27a4 Menorrhagia</li><li>\u27a4 Dysmenorrhoea</li><li>\u27a4 Infertility</li><li>\u27a4 Abdominal mass and pressure symptoms</li><li>\u27a4 Signs:</li><li>\u27a4 Signs:</li><li>\u27a4 Uterus regularly enlarged (single fibroid) or irregularly enlarged (multiple fibroids) Transmitted mobility is felt in a fibroid</li><li>\u27a4 Uterus regularly enlarged (single fibroid) or irregularly enlarged (multiple fibroids)</li><li>\u27a4 Transmitted mobility is felt in a fibroid</li><li>\u27a4 Ref: Page 376, DC Duttas\u2019s Textbook of Gynecology 8 th edition</li><li>\u27a4 Ref: Page 376, DC Duttas\u2019s Textbook of Gynecology 8 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9728220d",
      "audio": ""
    },
    {
      "text": "A 27-year woman who is anxious to conceive visits the OPD with her husband. They have been trying to conceive for 2 years. She has regular periods with heavy flow. There is associated dysmenorrhea. A transvaginal scan shows a submucosal fibroid of about 2 cm in size. What is the best management option?",
      "options": [
        {
          "label": "A",
          "text": "Laparoscopic myomectomy",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hysteroscopic myomectomy",
          "correct": true
        },
        {
          "label": "C",
          "text": "Reassurance",
          "correct": false
        },
        {
          "label": "D",
          "text": "GnRH agonists",
          "correct": false
        }
      ],
      "correct_answer": "B. Hysteroscopic myomectomy",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Hysteroscopic myomectomy</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 This patient is infertile and has a submucosal fibroid. The fibroid has to be removed. Type 0 and 1 submucosal fibroids are best removed hysteroscopically</li><li>\u2022 Other Options</li><li>\u2022 Other Options</li><li>\u2022 Option A: Laparoscopic myomectomy: Is indicated usually in intramural and subserosal fibroids Option B: Reassurance: Whenever an infertile patient has a submucosal fibroid or a large intra-mural fibroid, it has to be removed. Option C: GnRH agonist: Could have been tried if the patient did not have infertility.</li><li>\u2022 Option A: Laparoscopic myomectomy: Is indicated usually in intramural and subserosal fibroids</li><li>\u2022 Option A:</li><li>\u2022 Option B: Reassurance: Whenever an infertile patient has a submucosal fibroid or a large intra-mural fibroid, it has to be removed.</li><li>\u2022 Option B:</li><li>\u2022 Option C: GnRH agonist: Could have been tried if the patient did not have infertility.</li><li>\u2022 Option C:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Indications of myomectomy in infertility are: Submucous fibroids Large intramural fibroids distorting the cavity. Intramural fibroids > 5cm Submucosal fibroids are best removed hysteroscopically (Esp type 0 and type 1)</li><li>\u27a4 Indications of myomectomy in infertility are: Submucous fibroids Large intramural fibroids distorting the cavity. Intramural fibroids > 5cm</li><li>\u27a4 Submucous fibroids Large intramural fibroids distorting the cavity. Intramural fibroids > 5cm</li><li>\u27a4 Submucous fibroids</li><li>\u27a4 Large intramural fibroids distorting the cavity.</li><li>\u27a4 Intramural fibroids > 5cm</li><li>\u27a4 Submucosal fibroids are best removed hysteroscopically (Esp type 0 and type 1)</li><li>\u27a4 Ref: Page 376, DC Duttas\u2019s Textbook of Gynecology 8 th edition</li><li>\u27a4 Ref: Page 376, DC Duttas\u2019s Textbook of Gynecology 8 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "cf0898f1",
      "audio": ""
    },
    {
      "text": "You are assisting the surgeon in an abdominal myomectomy. The surgeon applies this instrument. Where would this be applied?",
      "options": [
        {
          "label": "A",
          "text": "At the infundibulopelvic ligaments",
          "correct": false
        },
        {
          "label": "B",
          "text": "At the level of round ligaments",
          "correct": false
        },
        {
          "label": "C",
          "text": "At the level of the internal os",
          "correct": true
        },
        {
          "label": "D",
          "text": "At the level of the fibroid",
          "correct": false
        }
      ],
      "correct_answer": "C. At the level of the internal os",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/1.jpg"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/1.jpg"
      ],
      "explanation": "<p><strong>Ans. C. At the level of the internal os</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 This is a Bonney\u2019s myomectomy clamp It is applied at the level of the uterine arteries  (level of internal os) during abdominal myomectomy to reduce the intra-operative blood loss by occluding the uterine arteries temporarily</li><li>\u2022 This is a Bonney\u2019s myomectomy clamp</li><li>\u2022 It is applied at the level of the uterine arteries  (level of internal os) during abdominal myomectomy to reduce the intra-operative blood loss by occluding the uterine arteries temporarily</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 This is a Bonney\u2019s myomectomy clamp It is applied at the level of the uterine arteries  (level of internal os) during abdominal myomectomy to reduce the intra-operative blood loss by occluding the uterine arteries temporarily</li><li>\u27a4 This is a Bonney\u2019s myomectomy clamp</li><li>\u27a4 It is applied at the level of the uterine arteries  (level of internal os) during abdominal myomectomy to reduce the intra-operative blood loss by occluding the uterine arteries temporarily</li><li>\u27a4 Ref: Page no 527, DC Dutta\u2019s Textbook of Gynecology 7 th edition</li><li>\u27a4 Ref: Page no 527, DC Dutta\u2019s Textbook of Gynecology 7 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e3e88c8e",
      "audio": ""
    },
    {
      "text": "The instrument shown below is useful in which surgery?",
      "options": [
        {
          "label": "A",
          "text": "Ovarian cystectomy",
          "correct": false
        },
        {
          "label": "B",
          "text": "Myomectomy",
          "correct": true
        },
        {
          "label": "C",
          "text": "Tubal recanalization",
          "correct": false
        },
        {
          "label": "D",
          "text": "Vaginal hysterectomy",
          "correct": false
        }
      ],
      "correct_answer": "B. Myomectomy",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/2.jpg"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/2.jpg"
      ],
      "explanation": "<p><strong>Ans. B. Myomectomy</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 The image is of a myoma screw. It is an instrument used in myomectomy. Myomectomy is a conservative surgery for fibroid uterus It can be performed via laparotomy or laparoscopically Risk of bleeding. This can be reduced Preoperatively GnRH agonists: They also reduce the size of the fibroid Correction of anemia/ blood transfusion Uterine Artery Embolization Intra-operatively Use of Bonney\u2019s uterine clamp/ uterine tourniquet (tied at the level of the uterine arteries) Use of vasopressin: injected along the planned serosal incision</li><li>\u2022 The image is of a myoma screw.</li><li>\u2022 It is an instrument used in myomectomy.</li><li>\u2022 Myomectomy is a conservative surgery for fibroid uterus It can be performed via laparotomy or laparoscopically Risk of bleeding. This can be reduced Preoperatively GnRH agonists: They also reduce the size of the fibroid Correction of anemia/ blood transfusion Uterine Artery Embolization Intra-operatively Use of Bonney\u2019s uterine clamp/ uterine tourniquet (tied at the level of the uterine arteries) Use of vasopressin: injected along the planned serosal incision</li><li>\u2022 It can be performed via laparotomy or laparoscopically Risk of bleeding. This can be reduced Preoperatively GnRH agonists: They also reduce the size of the fibroid Correction of anemia/ blood transfusion Uterine Artery Embolization Intra-operatively Use of Bonney\u2019s uterine clamp/ uterine tourniquet (tied at the level of the uterine arteries) Use of vasopressin: injected along the planned serosal incision</li><li>\u2022 It can be performed via laparotomy or laparoscopically</li><li>\u2022 Risk of bleeding. This can be reduced Preoperatively GnRH agonists: They also reduce the size of the fibroid Correction of anemia/ blood transfusion Uterine Artery Embolization</li><li>\u2022 Preoperatively GnRH agonists: They also reduce the size of the fibroid Correction of anemia/ blood transfusion Uterine Artery Embolization</li><li>\u2022 Preoperatively</li><li>\u2022 GnRH agonists: They also reduce the size of the fibroid</li><li>\u2022 Correction of anemia/ blood transfusion</li><li>\u2022 Uterine Artery Embolization</li><li>\u2022 Intra-operatively Use of Bonney\u2019s uterine clamp/ uterine tourniquet (tied at the level of the uterine arteries) Use of vasopressin: injected along the planned serosal incision</li><li>\u2022 Use of Bonney\u2019s uterine clamp/ uterine tourniquet (tied at the level of the uterine arteries) Use of vasopressin: injected along the planned serosal incision</li><li>\u2022 Use of Bonney\u2019s uterine clamp/ uterine tourniquet (tied at the level of the uterine arteries)</li><li>\u2022 Use of vasopressin: injected along the planned serosal incision</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The image is of a myoma screw. It is an instrument used in myomectomy.</li><li>\u27a4 The image is of a myoma screw.</li><li>\u27a4 It is an instrument used in myomectomy.</li><li>\u27a4 Ref: Page no 946, William\u2019s Gynecology 3 rd edition</li><li>\u27a4 Ref: Page no 946, William\u2019s Gynecology 3 rd edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d2910539",
      "audio": ""
    },
    {
      "text": "A 36-year lady presents with menorrhagia. On evaluation she is found to have a large intramural fibroid. A myomectomy is planned. All are beneficial in reducing blood loss during surgery except?",
      "options": [
        {
          "label": "A",
          "text": "Bonnie\u2019s clamp during surgery",
          "correct": false
        },
        {
          "label": "B",
          "text": "Bilateral Uterine artery ligation",
          "correct": false
        },
        {
          "label": "C",
          "text": "Ligation of vessels over the surface of the myoma",
          "correct": true
        },
        {
          "label": "D",
          "text": "Use of vasopressin along the planned serosal incision",
          "correct": false
        }
      ],
      "correct_answer": "C. Ligation of vessels over the surface of the myoma",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Ligation of vessels over the surface of the myoma</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Ligation of vessels over the surface of the myoma will not help reduce blood loss significantly during  a myomectomy</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Myomectomy is a conservative surgery for fibroid uterus It can be performed via laparotomy or laparoscopically Risk of bleeding. This can be reduced Preoperatively GnRH agonists: They also reduce the size of the fibroid Correction of anemia/ blood transfusion Uterine Artery Embolization Intra-operatively Use of Bonney\u2019s uterine clamp/ uterine tourniquet (tied at the level of the uterine arteries) Use of vasopressin: injected along the planned serosal incision</li><li>\u27a4 Myomectomy is a conservative surgery for fibroid uterus It can be performed via laparotomy or laparoscopically Risk of bleeding. This can be reduced</li><li>\u27a4 It can be performed via laparotomy or laparoscopically Risk of bleeding. This can be reduced</li><li>\u27a4 It can be performed via laparotomy or laparoscopically</li><li>\u27a4 Risk of bleeding. This can be reduced</li><li>\u27a4 Preoperatively GnRH agonists: They also reduce the size of the fibroid Correction of anemia/ blood transfusion Uterine Artery Embolization</li><li>\u27a4 GnRH agonists: They also reduce the size of the fibroid Correction of anemia/ blood transfusion Uterine Artery Embolization</li><li>\u27a4 GnRH agonists: They also reduce the size of the fibroid</li><li>\u27a4 Correction of anemia/ blood transfusion</li><li>\u27a4 Uterine Artery Embolization</li><li>\u27a4 Intra-operatively Use of Bonney\u2019s uterine clamp/ uterine tourniquet (tied at the level of the uterine arteries) Use of vasopressin: injected along the planned serosal incision</li><li>\u27a4 Use of Bonney\u2019s uterine clamp/ uterine tourniquet (tied at the level of the uterine arteries) Use of vasopressin: injected along the planned serosal incision</li><li>\u27a4 Use of Bonney\u2019s uterine clamp/ uterine tourniquet (tied at the level of the uterine arteries)</li><li>\u27a4 Use of vasopressin: injected along the planned serosal incision</li><li>\u27a4 Ref: Page no 946, William\u2019s Gynecology 3 rd edition</li><li>\u27a4 Ref: Page no 946, William\u2019s Gynecology 3 rd edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0e7de72f",
      "audio": ""
    },
    {
      "text": "A 45-year lady presents with heavy menstrual bleeding for 3 months. On examination, she does not appear to be pale. Her BP is 150/90mmHg. An abdominal and pelvic exam is normal. A transvaginal scan shows a 2 cm Intramural fibroid and an endometrial thickness of 15mm. both the ovaries appear normal What is the next best step?",
      "options": [
        {
          "label": "A",
          "text": "Endometrial Biopsy",
          "correct": true
        },
        {
          "label": "B",
          "text": "LNG-IUD",
          "correct": false
        },
        {
          "label": "C",
          "text": "Myomectomy",
          "correct": false
        },
        {
          "label": "D",
          "text": "Hysterectomy",
          "correct": false
        }
      ],
      "correct_answer": "A. Endometrial Biopsy",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Endometrial Biopsy</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 At 45y, heavy bleeding during periods could be because of endometrial hyperplasia or malignancy. It is important to rule out precancerous lesions and cancerous lesions at this age. A small 2 cm fibroid is unlikely to be the cause of her symptoms but her increased endometrial thickness on the ultrasound (15 mm is a thick endometrium for her age) could be alikely cause. Th is thickened endometrium warrants an endometrial biopsy to tule out endometrial hyperplasia and cancer</li><li>\u2022 At 45y, heavy bleeding during periods could be because of endometrial hyperplasia or malignancy.</li><li>\u2022 It is important to rule out precancerous lesions and cancerous lesions at this age.</li><li>\u2022 A small 2 cm fibroid is unlikely to be the cause of her symptoms but her increased endometrial thickness on the ultrasound (15 mm is a thick endometrium for her age) could be alikely cause.</li><li>\u2022 Th is thickened endometrium warrants an endometrial biopsy to tule out endometrial hyperplasia and cancer</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Fibroids and endometrial hyperplasia/ malignancy usually coexist as both are hyperestrogenic states Women in the peri-menopausal age group with fibroids with heavy menstrual bleeding should be evaluated for endometrial hyperplasia and cancer</li><li>\u27a4 Fibroids and endometrial hyperplasia/ malignancy usually coexist as both are hyperestrogenic states</li><li>\u27a4 Women in the peri-menopausal age group with fibroids with heavy menstrual bleeding should be evaluated for endometrial hyperplasia and cancer</li><li>\u27a4 Ref: Page no 946, William\u2019s Gynecology 3 rd edition</li><li>\u27a4 Ref: Page no 946, William\u2019s Gynecology 3 rd edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4e17c103",
      "audio": ""
    },
    {
      "text": "A 34-year with menorrhagia is diagnosed to have a submucosal fibroid with < 50% protrusion in the endometrial cavity. She is FIGO type?",
      "options": [
        {
          "label": "A",
          "text": "Type 0",
          "correct": false
        },
        {
          "label": "B",
          "text": "Type 1",
          "correct": false
        },
        {
          "label": "C",
          "text": "Type 2",
          "correct": true
        },
        {
          "label": "D",
          "text": "Type 3",
          "correct": false
        }
      ],
      "correct_answer": "C. Type 2",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/fibroid-2-1_UGbfyjY.jpg"
      ],
      "explanation": "<p><strong>Ans. C. Type 2</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 FIGO Classification of fibroids is as shown:</li><li>\u2022 Ref: https://obgyn.onlinelibrary.wiley.com/doi/10.1016/j.ijgo.2010.11.011</li><li>\u2022 Ref:</li><li>\u2022 https://obgyn.onlinelibrary.wiley.com/doi/10.1016/j.ijgo.2010.11.011</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7bef6d96",
      "audio": ""
    },
    {
      "text": "What is your interpretation of the following hysterosalpingogram?",
      "options": [
        {
          "label": "A",
          "text": "Normal",
          "correct": false
        },
        {
          "label": "B",
          "text": "Asherman syndrome",
          "correct": false
        },
        {
          "label": "C",
          "text": "B/l tubal block",
          "correct": false
        },
        {
          "label": "D",
          "text": "Submucosal fibroid",
          "correct": true
        }
      ],
      "correct_answer": "D. Submucosal fibroid",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/picture3_6tRXoo1.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Submucosal fibroid</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 This HSG shows a large well defined lesion in the uterus. This is most likely a submucosal fibroid</li><li>\u2022 This HSG shows a large well defined lesion in the uterus.</li><li>\u2022 This is most likely a submucosal fibroid</li><li>\u2022 Let us look at each option:</li><li>\u2022 Let us look at each option:</li><li>\u2022 Option A. Normal : A normal HSG would show a regular, symmetrically shaped uterine cavity without any filling defects or irregularities. The fallopian tubes would be visible, with the contrast material flowing freely through them, indicating patency . No obstructions or unusual shapes should be present.</li><li>\u2022 Option A.</li><li>\u2022 Normal</li><li>\u2022 Option B . Asherman syndrome : This condition is characterized by the presence of intrauterine adhesions or scar tissue. On an HSG, Asherman syndrome may present as irregular filling defects within the uterine cavity or as a generally diminished size of the uterine cavity, depending on the severity of the adhesions.</li><li>\u2022 Option B</li><li>\u2022 Asherman syndrome</li><li>\u2022 Option C. Bilateral tubal block (B/l tubal block) : In cases of bilateral tubal blockage, an HSG would show a lack of contrast material passing through one or both fallopian tubes ie. absence of free spill.</li><li>\u2022 Option C.</li><li>\u2022 Bilateral tubal block (B/l tubal block)</li><li>\u2022 Option D. Submucosal fibroid : They are fibroids that grow just beneath the lining of the uterine cavity. On an HSG, these would appear as filling defects within the uterine cavity. They might show as smooth, round, or lobulated contours projecting into the cavity, disrupting the otherwise smooth and regular shape of the uterus.</li><li>\u2022 Option D.</li><li>\u2022 Submucosal fibroid</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Ref: Page 440, Williams Gynecology 3 rd editionQuestion ID:19156</li><li>\u27a4 Ref: Page 440, Williams Gynecology 3 rd editionQuestion ID:19156</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "39ec2e8c",
      "audio": ""
    },
    {
      "text": "Which of the following is the gold standard technique for tubal evaluation?",
      "options": [
        {
          "label": "A",
          "text": "Hysterosalpingography",
          "correct": false
        },
        {
          "label": "B",
          "text": "Laparoscopic evaluation",
          "correct": true
        },
        {
          "label": "C",
          "text": "Saline infusion sonography",
          "correct": false
        },
        {
          "label": "D",
          "text": "Magnetic resonance imaging",
          "correct": false
        }
      ],
      "correct_answer": "B. Laparoscopic evaluation",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Laparoscopic evaluation</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 The following are tests done for tubal patency</li><li>\u2022 HSG (usually a preliminary test) Laparoscopic Chromotubation (Gold standard) Saline salpingography (better for intra uterine lesions) Others HyCoSy Falloposcopy</li><li>\u2022 HSG (usually a preliminary test)</li><li>\u2022 Laparoscopic Chromotubation (Gold standard)</li><li>\u2022 Saline salpingography (better for intra uterine lesions)</li><li>\u2022 Others HyCoSy Falloposcopy</li><li>\u2022 HyCoSy Falloposcopy</li><li>\u2022 HyCoSy</li><li>\u2022 Falloposcopy</li><li>\u2022 Let's review each option:</li><li>\u2022 Let's review each option:</li><li>\u2022 Option A. Hysterosalpingography (HSG) : This is a radiographic technique where a contrast dye is injected into the uterine cavity, and X-ray images are taken to visualize the uterus and fallopian tubes. HSG is primarily used for evaluating the internal shape of the uterus and the patency of the fallopian tubes. While it's a commonly used first-line investigation for tubal assessment in infertility evaluations, it provides limited information about the external contour of the tubes and surrounding structures.</li><li>\u2022 Option A.</li><li>\u2022 Hysterosalpingography (HSG)</li><li>\u2022 Option B. Laparoscopic Evaluation : Laparoscopy is considered the gold standard for tubal evaluation. It's a minimally invasive surgical procedure that provides a direct view of the pelvic organs, including the fallopian tubes. Laparoscopy not only allows for the assessment of tubal patency (often combined with chromopertubation, where a dye is passed through the tubes) but also enables visualization of the outer aspects of the tubes and the detection of other pelvic pathologies like endometriosis, adhesions, or fibroids that might affect tubal function. Its main limitation is that it's an invasive procedure requiring anesthesia.</li><li>\u2022 Option B.</li><li>\u2022 Laparoscopic Evaluation</li><li>\u2022 Option C . Saline Infusion Sonography (SIS) : SIS involves the infusion of saline into the uterine cavity during ultrasound examination. This technique  can be used to asses tubal patency,  it also enhances the visualization of the uterine cavity and can be useful in detecting abnormalities like polyps or fibroids.</li><li>\u2022 Option C</li><li>\u2022 Saline Infusion Sonography (SIS)</li><li>\u2022 Option D. Magnetic Resonance Imaging (MRI) : MRI can provide detailed images of the pelvic organs, including the uterus and fallopian tubes, without using ionizing radiation. It's particularly useful in assessing uterine anomalies and some types of fibroids. However, MRI is less commonly used for direct assessment of tubal patency or minor tubal abnormalities compared to laparoscopy or HSG.</li><li>\u2022 Option D.</li><li>\u2022 Magnetic Resonance Imaging (MRI)</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Page 441, Williams Gynecology 3 rd edition</li><li>\u27a4 Page 441, Williams Gynecology 3 rd edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "02422045",
      "audio": ""
    },
    {
      "text": "In treating hypertension, with beta blockers, which of the following semen parameter abnormalities may be seen?",
      "options": [
        {
          "label": "A",
          "text": "Azoospermia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Oligospermia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Teratospermia",
          "correct": false
        },
        {
          "label": "D",
          "text": "Low semen volume",
          "correct": true
        }
      ],
      "correct_answer": "D. Low semen volume",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Low semen volume</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Low semen volume often simply reflects incomplete specimen collection or short abstinence interval. However, it may indicate partial vas deferens obstruction or retrograde ejaculation. Partial or complete vas deferens obstruction may be caused by infection, tumor, prior testicular or inguinal surgery, or trauma. Retrograde ejaculation follows failed closure of the bladder neck during ejaculation and allows seminal fluid to flow backward into the bladder. Retrograde ejaculation is suspected in men with Diabetes mellitus Spinal cord damage Prior prostate or other retroperitoneal surgery that may have damaged nerves Medications (\u03b2-blockers)</li><li>\u2022 Low semen volume often simply reflects incomplete specimen collection or short abstinence interval.</li><li>\u2022 However, it may indicate partial vas deferens obstruction or retrograde ejaculation. Partial or complete vas deferens obstruction may be caused by infection, tumor, prior testicular or inguinal surgery, or trauma. Retrograde ejaculation follows failed closure of the bladder neck during ejaculation and allows seminal fluid to flow backward into the bladder. Retrograde ejaculation is suspected in men with Diabetes mellitus Spinal cord damage Prior prostate or other retroperitoneal surgery that may have damaged nerves Medications (\u03b2-blockers)</li><li>\u2022 Partial or complete vas deferens obstruction may be caused by infection, tumor, prior testicular or inguinal surgery, or trauma. Retrograde ejaculation follows failed closure of the bladder neck during ejaculation and allows seminal fluid to flow backward into the bladder. Retrograde ejaculation is suspected in men with Diabetes mellitus Spinal cord damage Prior prostate or other retroperitoneal surgery that may have damaged nerves Medications (\u03b2-blockers)</li><li>\u2022 Partial or complete vas deferens obstruction may be caused by infection, tumor, prior testicular or inguinal surgery, or trauma.</li><li>\u2022 Retrograde ejaculation follows failed closure of the bladder neck during ejaculation and allows seminal fluid to flow backward into the bladder. Retrograde ejaculation is suspected in men with Diabetes mellitus Spinal cord damage Prior prostate or other retroperitoneal surgery that may have damaged nerves Medications (\u03b2-blockers)</li><li>\u2022 Diabetes mellitus Spinal cord damage Prior prostate or other retroperitoneal surgery that may have damaged nerves Medications (\u03b2-blockers)</li><li>\u2022 Diabetes mellitus</li><li>\u2022 Spinal cord damage</li><li>\u2022 Prior prostate or other retroperitoneal surgery that may have damaged nerves</li><li>\u2022 Medications (\u03b2-blockers)</li><li>\u2022 A postejaculatory urinalysis can detect sperm in the bladder and confirm the diagnosis. If urine is properly alkalinized, these sperm are viable and can be retrieved to achieve pregnancy</li><li>\u2022 Let us explore the options given:</li><li>\u2022 Let us explore the options given:</li><li>\u2022 Option A. Azoospermia : This refers to the complete absence of sperm in the semen. While certain medications and health conditions can lead to azoospermia, beta-blockers are not typically associated with this severe a level of spermatogenic failure.</li><li>\u2022 Option A.</li><li>\u2022 Azoospermia</li><li>\u2022 Option B. Oligospermia : Oligospermia means a lower than normal sperm count. Some medications and health issues can lead to oligospermia, but beta-blockers are not commonly linked to significant decreases in sperm count.</li><li>\u2022 Option B.</li><li>\u2022 Oligospermia</li><li>\u2022 Option C. Teratospermia : Teratospermia is characterized by a high percentage of abnormally shaped sperm in the semen. This condition can be caused by various factors, including genetic defects, lifestyle choices, and exposure to certain chemicals or radiation. Beta-blockers are not known to specifically cause teratospermia.</li><li>\u2022 Option C.</li><li>\u2022 Teratospermia</li><li>\u2022 Option D. Low semen volume (Correct Answer): Beta-blockers can lead to a decrease in semen volume. This effect is thought to be related to the general inhibitory effects of beta-blockers on the sympathetic nervous system, which plays a role in seminal emission. As a result, men taking beta-blockers may experience a reduction in the volume of ejaculate.</li><li>\u2022 Option D.</li><li>\u2022 Low semen volume</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Ref: Page 443, Williams Gynecology 3 rd edition</li><li>\u27a4 Ref: Page 443, Williams Gynecology 3 rd edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e67eee02",
      "audio": ""
    },
    {
      "text": "Asthenospermia refers to which of the following semen abnormalities?",
      "options": [
        {
          "label": "A",
          "text": "Sperm count",
          "correct": false
        },
        {
          "label": "B",
          "text": "Semen volume",
          "correct": false
        },
        {
          "label": "C",
          "text": "Sperm motility",
          "correct": true
        },
        {
          "label": "D",
          "text": "Sperm morphology",
          "correct": false
        }
      ],
      "correct_answer": "C. Sperm motility",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/screenshot-2024-01-05-133945.jpg"
      ],
      "explanation": "<p><strong>Ans. C) Sperm motility</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Let's go through each option:</li><li>\u2022 Let's go through each option:</li><li>\u2022 Option A. Sperm Count : This refers to the concentration of sperm in a given volume of ejaculate. When the sperm count is lower than normal, it is termed oligospermia. Asthenospermia is not related to the count or concentration of sperm.</li><li>\u2022 Option A.</li><li>\u2022 Sperm Count</li><li>\u2022 Option B. Semen Volume : This is the total volume of the ejaculated fluid. A low semen volume can be due to various causes, including hormonal imbalances or blockages in the reproductive tract. However, asthenospermia does not pertain to the volume of semen.</li><li>\u2022 Option B.</li><li>\u2022 Semen Volume</li><li>\u2022 Option C. Sperm Motility (Correct Answer): Asthenospermia is specifically related to sperm motility, which refers to the ability of sperm to move efficiently. This is an important factor in fertility since sperm must be able to swim through the female reproductive tract to reach and fertilize the egg. Asthenospermia is characterized by a decreased percentage of motile sperm in the semen.</li><li>\u2022 Option C.</li><li>\u2022 Sperm Motility</li><li>\u2022 Option D. Sperm Morphology : This refers to the size and shape of sperm. Abnormalities in sperm morphology (teratospermia) can impact the ability of sperm to fertilize an egg. Asthenospermia, however, is specifically about the movement ability of sperm, not their shape or size.</li><li>\u2022 Option D.</li><li>\u2022 Sperm Morphology</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Ref: Page 443, Williams Gynecology 3 rd edition</li><li>\u27a4 Ref: Page 443, Williams Gynecology 3 rd edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d4ba7649",
      "audio": ""
    },
    {
      "text": "Which of the following tests can differentiate between dead and nonmotile sperm?",
      "options": [
        {
          "label": "A",
          "text": "Zona penetration assay",
          "correct": false
        },
        {
          "label": "B",
          "text": "DNA fragmentation index",
          "correct": false
        },
        {
          "label": "C",
          "text": "Hypoosmotic swelling test",
          "correct": true
        },
        {
          "label": "D",
          "text": "Mannose fluorescence assay",
          "correct": false
        }
      ],
      "correct_answer": "C. Hypoosmotic swelling test",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Hypoosmotic swelling test</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Ref: Page no 444, Williams Gynecology 3 rd edition</li><li>\u27a4 Ref: Page no 444, Williams Gynecology 3 rd edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8562671c",
      "audio": ""
    }
  ]
}